The	DT	det	O
transition	NN	nsubj	O
between	IN	case	O
both	DT	det	O
conformations	NNS	nmod	O
contributes	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
glycolysis	NN	nmod	O
and	CC	cc	O
is	VBZ	cop	O
important	JJ	conj	O
for	IN	case	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	nmod	O
and	CC	cc	O
survival	NN	conj	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
AND	CC	cc	O
OBJECTIVES	NNS	conj	O
:	:	punct	O
Aquaporins	NNS	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
AQPs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
play	VBP	dep	O
important	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
water	NN	nmod	B-Simple_chemical
and	CC	cc	O
glycerol	NN	compound	B-Simple_chemical
transport	NN	conj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
reverse	JJ	amod	O
transcription	NN	compound	O
-	HYPH	punct	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nsubjpass	O
and	CC	cc	O
prostaglandin	NN	compound	B-Simple_chemical
E	NN	conj	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
2	CD	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
(	-LRB-	punct	O
PGE	NN	compound	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
2	CD	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
)	-RRB-	punct	O
immunoassay	NN	conj	O
were	VBD	auxpass	O
performed	VBN	ROOT	O
to	TO	mark	O
verify	VB	xcomp	O
whether	IN	mark	O
BV	NN	nsubj	B-Organism_substance
possesses	VBZ	ccomp	O
an	DT	det	O
inhibitory	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
cyclooxygenase	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
COX	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
PGE	NN	compound	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
2	LS	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
synthesis	NN	conj	O
.	.	punct	O

sDll4	NN	nsubj	B-Gene_or_gene_product
similarly	RB	advmod	O
induced	VBD	ROOT	O
defective	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
response	NN	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
implants	NNS	nmod	O
leading	VBG	acl	O
to	TO	case	O
reduced	VBN	amod	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
evidence	NN	nsubj	O
for	IN	case	O
the	DT	det	O
implication	NN	nmod	O
of	IN	case	O
ARF	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

Three	CD	nummod	O
patients	NNS	nsubj	B-Organism
(	-LRB-	punct	O
14	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
regained	VBD	ROOT	O
2	CD	nummod	O
or	CC	cc	O
more	JJR	conj	O
lines	NNS	dobj	O
of	IN	case	O
visual	JJ	amod	O
acuity	NN	nmod	O
.	.	punct	O

The	DT	det	O
proinflammatory	JJ	amod	O
activities	NNS	nsubj	O
link	VBP	ROOT	O
TNF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	dobj	I-Gene_or_gene_product
with	IN	case	O
a	DT	det	O
wide	JJ	amod	O
variety	NN	nmod	O
of	IN	case	O
autoimmune	JJ	amod	O
diseases	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
psoriasis	NN	nmod	O
,	,	punct	O
inflammatory	JJ	amod	O
bowel	NN	compound	B-Organ
disease	NN	conj	O
,	,	punct	O
rheumatoid	JJ	amod	O
arthritis	NN	conj	O
,	,	punct	O
systemic	JJ	amod	O
sclerosis	NN	conj	O
,	,	punct	O
systemic	JJ	amod	O
lupus	NN	compound	O
erythematosus	NN	conj	O
,	,	punct	O
multiple	JJ	amod	O
sclerosis	NN	conj	O
,	,	punct	O
diabetes	NNS	conj	O
and	CC	cc	O
ankylosing	VBG	conj	O
spondylitis	NN	dobj	O
.	.	punct	O

Mutations	NNS	nsubj	O
affecting	VBG	acl	O
nuclear	JJ	amod	B-Cellular_component
transport	NN	dobj	O
were	VBD	cop	O
far	RB	advmod	O
more	RBR	advmod	O
critical	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
ability	NN	nmod	O
to	TO	mark	O
interfere	VB	acl	O
with	IN	case	O
myogenic	JJ	amod	O
differentiation	NN	nmod	O
than	IN	mark	O
were	VBD	cop	O
those	DT	advcl	O
affecting	VBG	acl	O
the	DT	det	O
transforming	VBG	amod	O
potential	NN	dobj	O
;	:	punct	O
cytoplasmic	JJ	amod	B-Organism_substance
SVLT	NN	compound	B-Gene_or_gene_product
expression	NN	nsubj	O
was	VBD	cop	O
fully	RB	advmod	O
compatible	JJ	parataxis	O
with	IN	case	O
the	DT	det	O
terminal	JJ	amod	O
differentiation	NN	nmod	O
of	IN	case	O
C2	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
despite	IN	mark	O
enabling	VBG	advcl	O
them	PRP	dobj	O
to	TO	aux	O
grow	VB	xcomp	O
in	IN	prep	O
semisolid	JJ	amod	O
medium	NN	pobj	O
,	,	punct	O
thus	RB	advmod	O
showing	VBG	xcomp	O
that	IN	mark	O
the	DT	det	O
myogenesis	NN	npadvmod	O
-	HYPH	punct	O
inhibiting	VBG	amod	O
property	NN	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
dissociated	VBN	ccomp	O
from	IN	case	O
transforming	VBG	amod	O
competence	NN	nmod	O
.	.	punct	O

Bmi	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
transgenic	JJ	amod	O
mice	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
born	VBN	ROOT	O
with	IN	case	O
enlarged	JJ	amod	O
lateral	JJ	amod	B-Multi-tissue_structure
ventricles	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
a	DT	det	O
minority	NN	conj	O
developed	VBD	conj	O
idiopathic	JJ	amod	O
hydrocephalus	NN	advmod	O
as	IN	case	O
adults	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
none	NN	nsubj	O
of	IN	case	O
the	DT	det	O
transgenic	JJ	amod	O
mice	NNS	nmod	B-Organism
formed	VBD	conj	O
detectable	JJ	amod	O
CNS	NN	compound	B-Cancer
tumors	NNS	dobj	I-Cancer
,	,	punct	O
even	RB	advmod	O
when	WRB	advmod	O
aged	JJ	advcl	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
in	FW	compound	O
vivo	FW	advmod	O
the	DT	det	O
regulation	NN	dobj	O
of	IN	case	O
leukocyte	NN	compound	B-Cell
-	HYPH	punct	O
vessel	NN	compound	B-Multi-tissue_structure
wall	NN	compound	I-Multi-tissue_structure
interactions	NNS	nmod	O
by	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
a	DT	det	O
tumor	NN	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
specific	JJ	amod	O
isoform	NN	compound	O
(	-LRB-	punct	O
s	NNS	nsubjpass	O
)	-RRB-	punct	O
of	IN	case	O
PKC	NN	nmod	B-Gene_or_gene_product
responsible	JJ	amod	O
for	IN	case	O
each	DT	nmod	O
of	IN	case	O
these	DT	det	O
changes	NNS	nmod	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
previously	RB	advmod	O
identified	VBN	ROOT	O
.	.	punct	O

VDAs	NNS	nsubjpass	B-Simple_chemical
can	MD	aux	O
be	VB	auxpass	O
divided	VBN	ROOT	O
into	IN	prep	O
biologics	NNS	pobj	O
,	,	punct	O
such	JJ	amod	O
as	IN	prep	O
ligand	NN	nmod:npmod	O
-	HYPH	punct	O
based	VBN	amod	O
,	,	punct	O
and	CC	cc	O
small	JJ	amod	O
-	HYPH	punct	O
molecule	NN	compound	O
agents	NNS	pobj	O
;	:	punct	O
this	DT	det	O
second	JJ	amod	O
group	NN	nsubj	O
includes	VBZ	parataxis	O
small	JJ	amod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
molecule	NN	compound	I-Simple_chemical
VDAs	NNS	dobj	I-Simple_chemical
like	IN	case	O
flavonoids	NNS	nmod	B-Simple_chemical
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
5	CD	nummod	B-Simple_chemical
,	,	punct	I-Simple_chemical
6	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dimethylxanthenone	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
4	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
acetic	JJ	amod	I-Simple_chemical
acid	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
DMXAA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
microtubule	JJ	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
destabilizing	VBG	amod	I-Simple_chemical
agents	NNS	conj	I-Simple_chemical
.	.	punct	O

The	DT	det	O
level	NN	nsubj	O
of	IN	case	O
apoptosis	NN	nmod	O
correlated	VBD	ROOT	O
directly	RB	advmod	O
with	IN	case	O
the	DT	det	O
expression	NN	compound	O
level	NN	nmod	O
of	IN	case	O
the	DT	det	O
receptor	NN	nmod	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
p75	NN	nsubj	B-Gene_or_gene_product
may	MD	aux	O
activate	VB	ccomp	O
the	DT	det	O
cell	NN	compound	B-Cell
death	NN	compound	O
program	NN	dobj	O
directly	RB	advmod	O
.	.	punct	O

U	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
995	CD	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
composed	VBN	ROOT	O
of	IN	case	O
two	CD	nummod	O
single	JJ	amod	O
peptides	NNS	nmod	O
with	IN	case	O
molecular	JJ	amod	O
mass	NN	nmod	O
of	IN	case	O
10	CD	nummod	O
and	CC	cc	O
14	CD	conj	O
kDa	NN	nmod	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Proof	NN	nsubj	O
of	IN	case	O
principle	NN	nmod	O
of	IN	case	O
the	DT	det	O
combined	JJ	amod	O
diagnosis	NN	compound	O
/	:	punct	O
treatment	NN	compound	O
system	NN	compound	O
design	NN	nsubjpass	O
for	IN	prep	O
performing	VBG	pcomp	O
dye	NN	npadvmod	O
-	HYPH	punct	O
enhanced	VBN	amod	O
photocoagulation	NN	dobj	O
(	-LRB-	punct	O
DEP	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
clinical	JJ	amod	O
setting	NN	nmod	O
and	CC	cc	O
determination	NN	conj	O
of	IN	case	O
the	DT	det	O
minimum	JJ	amod	O
DEP	NN	compound	O
laser	NN	compound	O
energy	NN	nmod	O
needed	VBD	acl	O
to	TO	case	O
close	VB	amod	O
CNV	NN	compound	O
FVs	NNS	nmod	B-Multi-tissue_structure
was	VBD	auxpass	O
made	VBN	ROOT	O
in	IN	case	O
11	CD	nummod	O
AMD	NN	compound	O
patients	NNS	nmod	B-Organism
requiring	VBG	acl	O
treatment	NN	dobj	O
of	IN	case	O
CNV	NN	nmod	O
,	,	punct	O
but	CC	cc	O
for	IN	case	O
whom	WP	nmod	O
other	JJ	amod	O
treatment	NN	nsubj	O
was	VBD	conj	O
not	RB	neg	O
appropriate	JJ	acomp	O
.	.	punct	O

An	DT	det	O
alternative	NN	amod	O
and	CC	cc	O
rather	RB	conj	O
obvious	JJ	conj	O
strategy	NN	nsubj	O
to	TO	case	O
treat	VB	compound	O
ischemia	NN	nmod	O
is	VBZ	ROOT	O
to	TO	mark	O
activate	VB	xcomp	O
endogenous	JJ	amod	O
angiogenic	JJ	dep	O
or	CC	cc	O
arteriogenic	JJ	conj	O
pathways	NNS	dobj	O
to	TO	mark	O
stimulate	VB	advcl	O
revascularization	NN	dobj	O
of	IN	case	O
the	DT	det	O
tissue	NN	nmod	B-Tissue
.	.	punct	O

miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
378	CD	nsubj	I-Gene_or_gene_product
,	,	punct	O
miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
296	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
the	DT	det	O
miR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
17	CD	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
92	CD	nummod	B-Gene_or_gene_product
cluster	NN	nsubj	O
contribute	VBP	ROOT	O
to	TO	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
.	.	punct	O

From	IN	prep	O
35	CD	quantmod	O
to	TO	quantmod	O
100	CD	nummod	O
%	NN	nsubjpass	O
of	IN	prep	O
the	DT	det	O
whole	JJ	amod	O
amount	NN	pobj	O
of	IN	prep	O
ATP	NN	pobj	B-Simple_chemical
resynthesized	VBD	acl	O
via	IN	case	O
glycolysis	NN	nmod	O
is	VBZ	auxpass	O
utilized	VBN	ROOT	O
for	IN	case	O
transport	NN	compound	O
purposes	NNS	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
concluded	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
observed	VBN	amod	O
increase	NN	nsubjpass	O
in	IN	case	O
the	DT	det	O
Na	NN	nmod	B-Simple_chemical
+	CC	cc	I-Simple_chemical
/	SYM	punct	O
K	NN	nmod	B-Simple_chemical
+	CC	cc	I-Simple_chemical
ratio	NN	conj	O
in	IN	case	O
ascites	VBZ	nmod	O
tumor	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
is	VBZ	auxpass	O
connected	VBN	ccomp	O
with	IN	case	O
their	PRP$	nmod:poss	O
enhanced	VBN	amod	O
ability	NN	nmod	O
to	TO	mark	O
synthesize	VB	acl	O
lactic	JJ	amod	B-Simple_chemical
acid	NN	dobj	I-Simple_chemical
.	.	punct	O

So	RB	advmod	O
we	PRP	nsubj	O
established	VBD	ROOT	O
that	IN	mark	O
these	DT	det	O
pathways	NNS	nsubj	O
were	VBD	cop	O
crucial	JJ	ccomp	O
to	TO	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	nmod	O
under	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
fibroblast	NN	compound	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
FGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
stimulation	NN	nmod	O
.	.	punct	O

Collectively	RB	advmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
furin	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
PLAG1	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
salivary	JJ	amod	B-Multi-tissue_structure
gland	NN	compound	I-Multi-tissue_structure
tumorigenesis	NN	nmod	O
in	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Genes	NNS	nsubj	O
most	RBS	advmod	O
significantly	RB	advmod	O
represented	VBN	ROOT	O
in	IN	case	O
this	DT	det	O
program	NN	nmod	O
are	VBP	cop	O
those	DT	nmod	O
with	IN	case	O
roles	NNS	nmod	O
in	IN	case	O
cell	NN	compound	B-Cell
growth	NN	dep	O
and	CC	cc	O
proliferation	NN	conj	O
>	NN	dep	O
protein	NN	compound	O
synthesis	NN	dep	O
>	NN	dep	O
gene	NN	compound	O
expression	NN	nmod	O
>	NN	dep	O
cell	NN	compound	B-Cell
death	NN	compound	O
>	NN	amod	O
cell	NN	compound	B-Cell
cycle	NN	dep	O
.	.	punct	O

Histologically	RB	advmod	O
,	,	punct	O
both	CC	det	O
2G7	NN	nmod:npmod	O
-	HYPH	punct	O
treated	VBN	amod	O
and	CC	cc	O
control	JJ	conj	O
tumors	NNS	nsubj	B-Cancer
were	VBD	cop	O
identical	JJ	ROOT	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
TEL	NN	nsubj	B-Gene_or_gene_product
inhibited	VBD	ROOT	O
the	DT	det	O
invasiveness	NN	dobj	O
of	IN	case	O
Ras	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
cells	NNS	nmod	B-Cell
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Western	NN	amod	O
blots	NNS	nsubj	O
confirmed	VBD	ROOT	O
that	IN	mark	O
LeTx	NN	compound	B-Simple_chemical
treatment	NN	nsubj	O
reduced	VBD	ccomp	O
the	DT	det	O
levels	NNS	dobj	O
of	IN	case	O
phosphorylated	VBN	amod	O
extracellular	JJ	amod	B-Gene_or_gene_product
signal	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
regulated	VBN	amod	I-Gene_or_gene_product
kinase	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
p38	NN	compound	B-Gene_or_gene_product
MAPK	NN	conj	I-Gene_or_gene_product
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
to	TO	mark	O
examine	VB	advcl	O
hypoxia	NN	compound	O
-	HYPH	punct	O
specific	JJ	amod	O
production	NN	dobj	O
of	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
therapeutic	JJ	amod	O
gene	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
constructed	VBD	ROOT	O
5	CD	nummod	O
copies	NNS	dobj	O
of	IN	case	O
HRE	NN	nmod	O
(	-LRB-	punct	O
5xHRE	CD	appos	O
)	-RRB-	punct	O
of	IN	case	O
human	JJ	amod	B-Organism
VEGF	NN	nmod	B-Gene_or_gene_product
linked	VBN	acl	O
to	TO	case	O
soluble	JJ	amod	O
Tie2	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
sTie2	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
driven	VBN	acl	O
by	IN	case	O
minimal	JJ	amod	O
SV40	NN	compound	B-Gene_or_gene_product
promoter	NN	nmod	O
(	-LRB-	punct	O
5xHRE	NN	dep	O
/	SYM	punct	O
SV40	NN	dep	B-Gene_or_gene_product
/	:	punct	O
sTie2	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

Assuming	VBG	amod	O
discrimination	NN	compound	O
thresholds	NNS	ROOT	O
between	IN	prep	O
high	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
grade	NN	nmod	I-Cancer
and	CC	cc	O
low	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
grade	NN	conj	I-Cancer
tumours	NNS	pobj	I-Cancer
of	IN	prep	O
0	CD	pobj	O
.	.	punct	O
8	CD	nummod	O
for	IN	case	O
18F	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FDG	NN	compound	I-Simple_chemical
uptake	NN	ROOT	O
and	CC	cc	O
1	CD	conj	O
.	.	punct	O
8	CD	ccomp	O
for	IN	case	O
123I	CD	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
IMT	NN	compound	I-Simple_chemical
uptake	NN	nmod	O
,	,	punct	O
the	DT	det	O
accuracy	NN	compound	O
values	NNS	nsubj	O
of	IN	case	O
18F	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FDG	NN	compound	I-Simple_chemical
PET	NN	dep	O
and	CC	cc	O
123I	CD	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
IMT	NN	conj	I-Simple_chemical
SPET	NN	nmod	O
for	IN	mark	O
differentiating	VBG	acl	O
between	IN	case	O
high	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
grade	NN	nmod	I-Cancer
and	CC	cc	O
low	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
grade	NN	compound	I-Cancer
tumours	NNS	conj	I-Cancer
were	VBD	ROOT	O
21	CD	nummod	O
/	SYM	punct	O
23	CD	nummod	O
(	-LRB-	punct	O
91	CD	nummod	O
%	NN	attr	O
)	-RRB-	punct	O
and	CC	cc	O
19	CD	nummod	O
/	SYM	punct	O
23	CD	nummod	O
(	-LRB-	punct	O
83	CD	nummod	O
%	NN	conj	O
)	-RRB-	punct	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Airway	NN	compound	B-Multi-tissue_structure
angiogenesis	NN	nsubjpass	O
and	CC	cc	O
microvascular	JJ	amod	B-Multi-tissue_structure
remodeling	NN	conj	O
are	VBP	auxpass	O
known	JJ	ROOT	O
features	NNS	dobj	O
of	IN	case	O
bronchial	JJ	amod	O
asthma	NN	nmod	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
mechanisms	NNS	nsubj	O
of	IN	case	O
these	DT	det	O
structural	JJ	amod	O
alterations	NNS	nmod	O
are	VBP	aux	O
just	RB	advmod	O
beginning	VBG	conj	O
to	TO	aux	O
be	VB	auxpass	O
elucidated	VBN	xcomp	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
mechanism	NN	compound	O
(	-LRB-	punct	O
s	NNS	nsubjpass	O
)	-RRB-	punct	O
by	IN	case	O
which	WDT	nmod	O
ciprofloxacin	NN	nsubj	B-Simple_chemical
elicits	VBZ	acl:relcl	O
its	PRP$	nmod:poss	O
biological	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
bladder	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
is	VBZ	auxpass	O
not	RB	neg	O
well	RB	advmod	O
documented	VBN	ROOT	O
.	.	punct	O

Thrombin	NN	nsubj	B-Gene_or_gene_product
increases	VBZ	ROOT	O
the	DT	det	O
mRNA	NN	compound	O
and	CC	cc	O
protein	NN	conj	O
levels	NNS	dobj	O
of	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
v	LS	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
3	LS	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
integrin	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
serves	VBZ	conj	O
as	IN	case	O
a	DT	det	O
ligand	NN	nmod	O
to	TO	case	O
this	DT	det	O
receptor	NN	nmod	O
.	.	punct	O

In	IN	case	O
T	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
ALL	NN	nmod	I-Cancer
with	IN	case	O
t	NN	compound	O
(	-LRB-	punct	O
10	CD	dep	O
;	:	punct	O
14	CD	dep	O
)	-RRB-	punct	O
translocation	NN	nmod	O
,	,	punct	O
the	DT	det	O
HOX	NN	compound	B-Gene_or_gene_product
11	CD	nummod	I-Gene_or_gene_product
gene	NN	nsubjpass	O
is	VBZ	auxpass	O
deregulated	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
in	FW	amod	O
vivo	FW	dep	O
role	NN	nsubjpass	O
of	IN	case	O
9E3	NN	compound	B-Gene_or_gene_product
/	:	punct	O
CEF4	NN	nmod	B-Gene_or_gene_product
may	MD	aux	O
be	VB	auxpass	O
involved	VBN	ROOT	O
with	IN	case	O
chemotaxis	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
,	,	punct	O
rather	RB	advmod	O
than	IN	mwe	O
with	IN	case	O
direct	JJ	amod	O
stimulation	NN	nmod	O
of	IN	case	O
mitogenicity	NN	nmod	O
.	.	punct	O

This	DT	det	O
review	NN	nsubj	O
will	MD	aux	O
summarize	VB	ROOT	O
the	DT	det	O
current	JJ	amod	O
position	NN	dobj	O
of	IN	case	O
CECs	NNS	nmod	B-Cell
,	,	punct	O
EPCs	NNS	conj	B-Cell
and	CC	cc	O
EMPs	NNS	conj	B-Cellular_component
in	IN	case	O
cell	NN	compound	B-Cell
biology	NN	compound	O
terms	NNS	nmod	O
,	,	punct	O
with	IN	case	O
particular	JJ	amod	O
emphasis	NN	nmod	O
on	IN	case	O
their	PRP$	nmod:poss	O
relationship	NN	nmod	O
to	TO	case	O
malignant	JJ	amod	B-Cancer
disease	NN	nmod	I-Cancer
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
produced	VBD	ROOT	O
a	DT	det	O
neutralizing	VBG	amod	O
antibody	NN	dobj	O
,	,	punct	O
1B3	NN	appos	B-Simple_chemical
,	,	punct	O
directed	VBN	acl	O
against	IN	case	O
mouse	NN	compound	B-Organism
PDGFRbeta	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

When	WRB	advmod	O
the	DT	det	O
patients	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
divided	VBN	ROOT	O
into	IN	case	O
two	CD	nummod	O
groups	NNS	nmod	O
according	VBG	prep	O
to	IN	mwe	O
their	PRP$	nmod:poss	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
SMA	NN	compound	I-Gene_or_gene_product
expression	NN	pobj	O
using	VBG	advcl	O
a	DT	det	O
cutoff	NN	compound	O
point	NN	dobj	O
at	IN	case	O
the	DT	det	O
mean	NN	amod	O
value	NN	nmod	O
of	IN	case	O
8	CD	nmod	O
.	.	punct	O
48	CD	nummod	O
%	NN	npadvmod	O
,	,	punct	O
the	DT	det	O
high	JJ	amod	O
alpha	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
SMA	NN	compound	I-Gene_or_gene_product
group	NN	nsubj	O
had	VBD	ROOT	O
a	DT	det	O
significantly	RB	advmod	O
poorer	VBN	amod	O
overall	JJ	amod	O
survival	NN	compound	O
rate	NN	dobj	O
(	-LRB-	punct	O
p	NN	compound	O
<	CD	appos	O
0	CD	nummod	O
.	.	punct	O
001	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
could	MD	aux	O
explain	VB	ROOT	O
the	DT	dep	O
angiogenic	JJ	dobj	O
and	CC	cc	O
tumor	NN	conj	B-Cancer
-	HYPH	punct	O
promoting	VBG	dep	O
effect	NN	dep	O
of	IN	case	O
thrombin	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
provide	VBP	conj	O
the	DT	det	O
basis	NN	dobj	O
for	IN	case	O
development	NN	nmod	O
of	IN	case	O
thrombin	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
mimetics	NNS	nmod	O
or	CC	cc	O
antagonists	NNS	conj	O
for	IN	case	O
therapeutic	JJ	amod	O
application	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
heterozygous	JJ	amod	O
disruption	NN	nsubj	O
of	IN	case	O
beclin	NN	nmod	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
increases	VBZ	ccomp	O
the	DT	det	O
frequency	NN	dobj	O
of	IN	case	O
spontaneous	JJ	amod	O
malignancies	NNS	nmod	B-Cancer
and	CC	cc	O
accelerates	VBZ	conj	O
the	DT	det	O
development	NN	dobj	O
of	IN	case	O
hepatitis	NN	compound	B-Organism
B	NN	compound	I-Organism
virus	NN	npadvmod	I-Organism
-	:	punct	O
induced	VBN	amod	O
premalignant	JJ	amod	B-Pathological_formation
lesions	NNS	nmod	I-Pathological_formation
.	.	punct	O

TEL	NN	nsubj	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
putative	JJ	amod	O
tumor	NN	compound	B-Cancer
suppressor	NN	appos	O
,	,	punct	O
modulates	VBZ	ROOT	O
cell	NN	compound	B-Cell
growth	NN	dobj	O
and	CC	cc	O
cell	NN	compound	B-Cell
morphology	NN	conj	O
of	IN	case	O
ras	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
cells	NNS	nmod	B-Cell
while	IN	mark	O
repressing	VBG	advcl	O
the	DT	det	O
transcription	NN	dobj	O
of	IN	case	O
stromelysin	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Therapeutic	JJ	amod	O
targeting	NN	ROOT	O
of	IN	case	O
the	DT	det	O
survivin	NN	compound	B-Gene_or_gene_product
pathway	NN	nmod	O
in	IN	case	O
cancer	NN	nmod	B-Cancer
:	:	punct	O
initiation	NN	dep	O
of	IN	case	O
mitochondrial	JJ	amod	B-Cellular_component
apoptosis	NN	nmod	O
and	CC	cc	O
suppression	NN	conj	O
of	IN	case	O
tumor	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
associated	VBN	amod	O
angiogenesis	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
high	JJ	amod	O
mortality	NN	nsubj	O
observed	VBN	acl	O
in	IN	case	O
the	DT	det	O
folate	JJ	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
deficient	JJ	amod	O
group	NN	nmod	O
precludes	VBZ	ROOT	O
a	DT	det	O
definitive	JJ	amod	O
conclusion	NN	dobj	O
concerning	VBG	case	O
the	DT	det	O
effect	NN	nmod	O
of	IN	case	O
folate	JJ	compound	B-Simple_chemical
deficiency	NN	nmod	O
on	IN	case	O
UC	NNP	nmod:npmod	B-Pathological_formation
-	HYPH	punct	O
associated	VBN	amod	O
colorectal	JJ	amod	B-Multi-tissue_structure
carcinogenesis	NN	nmod	O
in	IN	case	O
this	DT	det	O
model	NN	nmod	O
.	.	punct	O

[	-LRB-	ROOT	O
Autologous	JJ	amod	O
bone	NN	compound	B-Cell
marrow	NN	compound	I-Cell
stem	NN	compound	I-Cell
cell	NN	intj	I-Cell
or	CC	cc	O
peripheral	JJ	amod	B-Cell
blood	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
progenitor	NN	compound	I-Cell
cell	NN	compound	I-Cell
therapy	NN	conj	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
peripheral	JJ	amod	O
limb	NN	compound	B-Organism_subdivision
ischaemia	NN	nmod	O
]	-RRB-	punct	O

The	DT	det	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
product	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
considered	VBN	ROOT	O
as	IN	case	O
an	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
metastatic	JJ	amod	O
protein	NN	nmod	O
and	CC	cc	O
the	DT	det	O
level	NN	nsubjpass	O
of	IN	case	O
its	PRP$	nmod:poss	O
expression	NN	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
reported	VBN	conj	O
to	TO	mark	O
correlate	VB	xcomp	O
inversely	RB	advmod	O
with	IN	case	O
metastatic	JJ	amod	O
potential	NN	nmod	O
in	IN	case	O
some	DT	det	O
cancers	NNS	nmod	B-Cancer
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
Patients	NNS	nsubjpass	B-Organism
diagnosed	VBN	acl	O
with	IN	case	O
chronic	JJ	amod	O
CSC	NN	nmod	O
,	,	punct	O
with	IN	case	O
clinical	JJ	amod	O
evidence	NN	nmod	O
of	IN	case	O
activity	NN	nmod	O
and	CC	cc	O
treated	VBN	conj	O
with	IN	case	O
Photodynamic	NNP	compound	O
Therapy	NNP	nmod	O
,	,	punct	O
are	VBP	auxpass	O
included	VBN	ROOT	O
in	IN	case	O
this	DT	det	O
report	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
supplementation	NN	nsubj	O
with	IN	case	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Carnitine	NNP	nmod	I-Simple_chemical
as	IN	case	O
an	DT	det	O
adjuvant	JJ	amod	O
therapy	NN	nmod	O
may	MD	aux	O
be	VB	aux	O
promising	JJ	ROOT	O
in	IN	prep	O
alleviating	VBG	pcomp	O
the	DT	det	O
systemic	JJ	amod	O
side	NN	compound	O
-	HYPH	punct	O
effects	NNS	dobj	O
of	IN	prep	O
chemotherapeutics	NNS	pobj	O
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
ING4	NN	nmod	B-Gene_or_gene_product
is	VBZ	auxpass	O
significantly	RB	advmod	O
reduced	VBN	ROOT	O
in	IN	case	O
gliomas	NNS	nmod	B-Cancer
as	IN	mark	O
compared	VBN	advcl	O
with	IN	case	O
normal	JJ	amod	O
human	JJ	amod	B-Organism
brain	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
,	,	punct	O
and	CC	cc	O
the	DT	det	O
extent	NN	nsubj	O
of	IN	case	O
reduction	NN	nmod	O
correlates	VBZ	conj	O
with	IN	case	O
the	DT	det	O
progression	NN	nmod	O
from	IN	case	O
lower	JJR	nmod	O
to	IN	case	O
higher	JJR	amod	O
grades	NNS	nmod	O
of	IN	prep	O
tumours	NNS	pobj	B-Cancer
.	.	punct	O

LDH5	NN	compound	B-Gene_or_gene_product
overexpression	NN	nsubjpass	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
histological	JJ	amod	O
type	NN	nmod	O
(	-LRB-	punct	O
adenocarcinoma	NN	dep	B-Cancer
=	JJ	amod	O
57	CD	nummod	O
%	NN	dobj	O
,	,	punct	O
squamous	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nsubj	I-Cancer
=	JJ	dep	O
45	CD	nummod	O
%	NN	dobj	O
,	,	punct	O
large	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nsubj	I-Cancer
=	JJ	dep	O
46	CD	nummod	O
%	NN	dobj	O
,	,	punct	O
p	NN	nsubj	O
=	JJ	parataxis	O
0	CD	dobj	O
.	.	punct	O
006	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

AIMS	NNS	ROOT	O
:	:	punct	O
As	IN	mark	O
one	CD	pobj	O
of	IN	case	O
the	DT	det	O
five	CD	nummod	O
lactate	NN	compound	B-Gene_or_gene_product
dehydrogenase	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
LDH	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
isoenzymes	NNS	nmod	O
,	,	punct	O
LDH5	NN	nsubj	B-Gene_or_gene_product
has	VBZ	dep	O
the	DT	det	O
highest	JJS	amod	O
efficiency	NN	dobj	O
to	TO	mark	O
catalyze	VB	acl	O
pyruvate	NN	compound	B-Simple_chemical
transformation	NN	dobj	O
to	TO	aux	O
lactate	VB	xcomp	B-Simple_chemical
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
define	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
function	NN	dobj	O
of	IN	case	O
Evi	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
as	IN	case	O
a	DT	det	O
repressor	NN	nmod	O
of	IN	case	O
signaling	VBG	compound	O
components	NNS	nmod	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

When	WRB	advmod	O
MDV	NN	nsubjpass	B-Organism
was	VBD	auxpass	O
reactivated	VBN	advcl	O
by	IN	case	O
treatment	NN	nmod	O
of	IN	case	O
lymphoblastoid	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
25	CD	nummod	O
micrograms	NNS	nmod	O
of	IN	case	O
iododeoxyuridine	NN	nmod	B-Simple_chemical
per	IN	case	O
ml	NN	nmod	O
,	,	punct	O
the	DT	det	O
relative	JJ	amod	O
levels	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
transcripts	NNS	nmod	O
decreased	VBD	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
ING4	NN	nsubj	B-Gene_or_gene_product
physically	RB	advmod	O
interacts	VBZ	ccomp	O
with	IN	case	O
p65	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
RelA	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
subunit	NN	nmod	O
of	IN	case	O
nuclear	JJ	amod	O
factor	NN	compound	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
ING4	NN	nsubj	B-Gene_or_gene_product
regulates	VBZ	conj	O
brain	NN	compound	B-Cancer
tumour	NN	compound	I-Cancer
angiogenesis	NN	dobj	O
through	IN	case	O
transcriptional	JJ	amod	O
repression	NN	nmod	O
of	IN	case	O
NF	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
responsive	JJ	amod	O
genes	NNS	nmod	O
.	.	punct	O

Two	CD	nummod	O
distraction	NN	compound	O
rates	NNS	nsubjpass	O
(	-LRB-	punct	O
0	CD	nummod	O
.	.	punct	O
5	CD	dep	O
and	CC	cc	O
1	CD	conj	O
mm	NN	dep	O
/	SYM	punct	O
day	NN	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
compared	VBN	ROOT	O
and	CC	cc	O
for	IN	case	O
each	DT	det	O
group	NN	conj	O
three	CD	nummod	O
patients	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
analyzed	VBN	parataxis	O
.	.	punct	O

Because	IN	mark	O
the	DT	det	O
intravenously	RB	advmod	B-Immaterial_anatomical_entity
injected	JJ	amod	O
lipoplexes	NNS	nsubj	B-Simple_chemical
migrated	VBD	advcl	O
within	IN	case	O
seconds	NNS	nmod	O
to	IN	case	O
lungs	NNS	xcomp	B-Organ
,	,	punct	O
we	PRP	nsubj	O
checked	VBD	ROOT	O
whether	IN	mark	O
the	DT	det	O
effects	NNS	nsubj	O
of	IN	case	O
immediate	JJ	amod	O
contact	NN	nmod	O
with	IN	case	O
serum	NN	nmod	B-Organism_substance
correlate	VBP	ccomp	O
with	IN	case	O
lung	NN	compound	B-Organ
lipofection	NN	compound	O
efficiency	NN	nmod	O
of	IN	case	O
different	JJ	amod	O
DOTAP	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
based	VBN	amod	O
formulations	NNS	nmod	O
.	.	punct	O

Cyclin	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
dependent	JJ	amod	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
activity	NN	nsubjpass	O
,	,	punct	O
p107	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
cyclin	NN	compound	B-Gene_or_gene_product
A	NN	conj	I-Gene_or_gene_product
levels	NNS	conj	O
,	,	punct	O
and	CC	cc	O
retinoblastoma	NN	compound	B-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
phosphorylation	NN	nsubjpass	O
are	VBP	auxpass	O
markedly	RB	advmod	O
reduced	VBN	ROOT	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
the	DT	det	O
addition	NN	nmod	O
of	IN	case	O
exogenous	JJ	amod	O
SPARC	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
peptides	NNS	conj	O
derived	VBN	acl	O
from	IN	case	O
specific	JJ	amod	O
domains	NNS	nmod	O
of	IN	case	O
SPARC	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Tumors	NNS	ROOT	B-Cancer
of	IN	case	O
the	DT	det	O
retinal	JJ	amod	B-Tissue
pigment	NN	amod	I-Tissue
epithelium	NN	compound	I-Tissue
metastasize	NN	nmod	O
to	TO	case	O
inguinal	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
spleen	NN	conj	B-Organ
in	IN	case	O
tyrosinase	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
related	JJ	amod	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
/	:	punct	O
SV40	NN	compound	B-Gene_or_gene_product
T	NN	compound	I-Gene_or_gene_product
antigen	NN	compound	I-Gene_or_gene_product
transgenic	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

The	DT	det	O
angiogenic	JJ	amod	O
potency	NN	nsubj	O
of	IN	case	O
adipose	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
was	VBD	cop	O
not	RB	neg	O
related	JJ	ROOT	O
to	TO	case	O
its	PRP$	nmod:poss	O
localization	NN	nmod	O
(	-LRB-	punct	O
with	IN	case	O
an	DT	det	O
angiogenic	JJ	amod	O
stimulation	NN	nmod	O
in	IN	case	O
60	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
SAT	NN	compound	B-Tissue
samples	NNS	nmod	I-Tissue
and	CC	cc	O
61	CD	nummod	O
%	NN	conj	O
of	IN	case	O
VAT	NN	compound	B-Tissue
samples	NNS	nmod	I-Tissue
)	-RRB-	punct	O
or	CC	cc	O
to	TO	case	O
adipocyte	NN	compound	B-Cell
size	NN	conj	O
or	CC	cc	O
inflammatory	JJ	amod	O
infiltrate	NN	conj	O
assessed	VBN	acl	O
in	IN	case	O
adipose	NN	compound	B-Tissue
samples	NNS	nmod	I-Tissue
before	IN	case	O
the	DT	det	O
graft	NN	nmod	B-Tissue
on	IN	case	O
CAM	NN	nmod	B-Multi-tissue_structure
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
the	DT	det	O
level	NN	nsubj	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
product	NN	compound	O
expression	NN	nmod	O
does	VBZ	aux	O
not	RB	neg	O
significantly	RB	advmod	O
reveal	VB	ROOT	O
prognostic	JJ	amod	O
value	NN	dobj	O
in	IN	case	O
node	NN	nmod:npmod	B-Cancer
-	HYPH	punct	I-Cancer
positive	JJ	amod	I-Cancer
lung	NN	compound	I-Cancer
cancers	NNS	nmod	I-Cancer
.	.	punct	O

By	IN	case	O
use	NN	nmod	O
of	IN	case	O
electric	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
MSH	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
6	CD	appos	O
)	-RRB-	punct	O
to	TO	case	O
10	CD	nummod	O
(	-LRB-	punct	O
-	:	punct	O
14	CD	nummod	O
)	-RRB-	punct	O
M	NN	nsubj	O
)	-RRB-	punct	O
activates	VBZ	ccomp	O
AP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dobj	I-Gene_or_gene_product
in	IN	case	O
human	JJ	amod	B-Organism
dermal	JJ	amod	B-Cell
fibroblasts	NNS	nmod	I-Cell
,	,	punct	O
whereas	IN	dep	O
coincubation	NN	nsubj	O
with	IN	case	O
interleukin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
beta	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
beta	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
results	VBZ	parataxis	O
in	IN	case	O
suppression	NN	nmod	O
of	IN	case	O
its	PRP$	nmod:poss	O
activation	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
provide	VBP	ROOT	O
the	DT	det	O
first	JJ	amod	O
evidence	NN	dobj	O
that	IN	mark	O
,	,	punct	O
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
in	IN	case	O
rat	NN	compound	B-Organism
mammary	JJ	amod	B-Cancer
carcinomas	NNS	conj	I-Cancer
that	WDT	nsubj	O
have	VBP	acl:relcl	O
an	DT	det	O
induced	VBN	amod	O
increase	NN	dobj	O
in	IN	case	O
neu	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
,	,	punct	O
a	DT	det	O
consistent	JJ	amod	O
and	CC	cc	O
substantial	JJ	conj	O
increase	NN	nsubj	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
specific	JJ	amod	O
PTPases	NNS	nmod	B-Gene_or_gene_product
occurs	VBZ	acl:relcl	O
.	.	punct	O

The	DT	det	O
conclusion	NN	nsubj	O
most	RBS	advmod	O
consistent	JJ	amod	O
with	IN	case	O
the	DT	det	O
data	NNS	nmod	O
is	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
two	CD	nummod	O
MSRs	NNS	nsubj	B-Gene_or_gene_product
are	VBP	aux	O
overlapping	VBG	ccomp	O
,	,	punct	O
spliced	VBN	amod	O
RNAs	NNS	dobj	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
used	VBD	ROOT	O
JB6	NN	compound	O
P	NN	dobj	O
+	CC	cc	O
mouse	NN	compound	B-Organism
epidermal	JJ	amod	O
cells	NNS	conj	O
and	CC	cc	O
AP	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
-	HYPH	punct	O
luciferase	NN	nmod:npmod	B-Gene_or_gene_product
reporter	NN	nmod:npmod	O
transgenic	JJ	amod	O
mice	NNS	conj	B-Organism
to	TO	mark	O
identify	VB	advcl	O
whether	IN	mark	O
exposure	NN	nsubj	O
to	IN	case	O
Cum	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
OOH	NNP	nmod	I-Simple_chemical
caused	VBD	ccomp	O
activation	NN	dobj	O
of	IN	case	O
AP	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
oxidative	JJ	amod	O
stress	NN	nmod	O
,	,	punct	O
depletion	NN	conj	O
of	IN	case	O
antioxidants	NNS	nmod	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
formation	NN	conj	O
during	IN	case	O
two	CD	nummod	O
-	HYPH	punct	O
stage	NN	compound	O
carcinogenesis	NN	nmod	O
.	.	punct	O

Truncated	VBN	amod	O
galectin	NN	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
inhibits	VBZ	ROOT	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
and	CC	cc	O
metastasis	NN	conj	O
in	IN	case	O
orthotopic	JJ	amod	O
nude	JJ	amod	B-Organism
mouse	NN	compound	I-Organism
model	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Because	IN	mark	O
islet	NN	compound	B-Multi-tissue_structure
inflammation	NN	nsubj	O
may	MD	aux	O
originate	VB	advcl	O
from	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
we	PRP	nsubj	O
assessed	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
selected	VBN	amod	O
genes	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
activation	NN	nmod	O
in	IN	case	O
islets	NNS	nmod	B-Multi-tissue_structure
from	IN	case	O
a	DT	det	O
spontaneous	JJ	amod	O
model	NN	nmod	O
of	IN	case	O
type	NN	compound	O
2	CD	nummod	O
diabetes	NNS	nmod	O
,	,	punct	O
the	DT	det	O
Goto	NN	compound	B-Organism
-	HYPH	punct	I-Organism
Kakizaki	NNP	compound	I-Organism
(	-LRB-	punct	I-Organism
GK	NN	appos	I-Organism
)	-RRB-	punct	I-Organism
rat	NN	dobj	I-Organism
.	.	punct	O

The	DT	det	O
most	RBS	advmod	O
common	JJ	amod	O
genetic	JJ	amod	O
alterations	NNS	nsubj	O
found	VBN	acl	O
in	IN	case	O
a	DT	det	O
wide	JJ	amod	O
variety	NN	nmod	O
of	IN	case	O
cancers	NNS	nmod	B-Cancer
are	VBP	cop	O
p53	NN	compound	B-Gene_or_gene_product
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
gene	NN	compound	O
mutations	NNS	ROOT	O
.	.	punct	O

p63	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
carcinomas	NNS	nsubjpass	O
were	VBD	auxpass	O
poorly	RB	advmod	O
differentiated	VBN	amod	O
,	,	punct	O
hormone	NN	compound	O
receptor	NN	nmod:npmod	O
-	HYPH	punct	O
negative	JJ	amod	O
neoplasms	NNS	ROOT	B-Cancer
with	IN	case	O
a	DT	det	O
high	JJ	amod	O
proliferation	NN	compound	O
rate	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
Bmi	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
over	IN	dep	O
-	HYPH	punct	O
expression	NN	nsubj	O
had	VBD	ROOT	O
little	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
CNS	NN	compound	B-Cell
stem	NN	compound	I-Cell
cell	NN	compound	I-Cell
frequency	NN	nmod	O
,	,	punct	O
subventricular	JJ	amod	B-Immaterial_anatomical_entity
zone	NN	compound	I-Immaterial_anatomical_entity
proliferation	NN	conj	O
,	,	punct	O
olfactory	JJ	amod	B-Multi-tissue_structure
bulb	NN	nmod:poss	I-Multi-tissue_structure
neurogenesis	NN	conj	O
,	,	punct	O
or	CC	cc	O
neurogenesis	NN	conj	O
/	:	punct	O
gliogenesis	NN	conj	O
during	IN	prep	O
development	NN	pobj	O
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
inhibition	NN	nsubjpass	O
was	VBD	auxpass	O
achieved	VBN	ROOT	O
by	IN	case	O
IkappaBalpha	NN	compound	B-Gene_or_gene_product
super	NN	amod	O
-	HYPH	punct	O
repressor	NN	compound	O
adenoviral	JJ	amod	B-Organism
vector	NN	nmod	O
and	CC	cc	O
activation	NN	conj	O
was	VBD	auxpass	O
monitored	VBN	conj	O
by	IN	case	O
EMSA	NN	nmod	O
and	CC	cc	O
reporter	NN	compound	O
assays	NNS	conj	O
.	.	punct	O

Bolus	NN	compound	O
incubation	NN	nsubjpass	O
was	VBD	auxpass	O
carried	VBN	ROOT	O
out	RP	prt	O
to	TO	mark	O
determine	VB	xcomp	O
effects	NNS	dobj	O
of	IN	case	O
doxorubicin	NN	nmod	B-Simple_chemical
accumulated	VBN	acl	O
during	IN	case	O
the	DT	det	O
first	JJ	amod	O
3h	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
continuous	JJ	amod	O
incubation	NN	nsubj	O
allowed	VBD	parataxis	O
further	RB	amod	O
(	-LRB-	punct	O
continuous	JJ	amod	O
)	-RRB-	punct	O
exposure	NN	dobj	O
to	TO	case	O
doxorubicin	NN	nmod	B-Simple_chemical
.	.	punct	O

Previous	JJ	amod	O
work	NN	nsubj	O
demonstrates	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
LMP1	NN	compound	B-Gene_or_gene_product
gene	NN	nsubj	O
of	IN	case	O
EBV	NN	nmod	B-Organism
is	VBZ	cop	O
sufficient	JJ	ccomp	O
to	TO	mark	O
transform	VB	xcomp	O
certain	JJ	amod	O
established	JJ	amod	O
rodent	JJ	amod	O
fibroblast	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	dobj	I-Cell
and	CC	cc	O
to	TO	mark	O
induce	VB	conj	O
the	DT	det	O
tumorigenicity	NN	dobj	O
of	IN	case	O
some	DT	det	O
human	JJ	amod	B-Organism
epithelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

Angiopoietin	NN	nsubj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
prevents	VBZ	ROOT	O
VEGF	NNP	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
endothelial	JJ	amod	B-Tissue
permeability	NN	dobj	O
by	IN	prep	O
sequestering	VBG	pcomp	O
Src	NNP	dobj	B-Gene_or_gene_product
through	IN	prep	O
mDia	NNS	pobj	B-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
rationale	NN	nsubjpass	O
for	IN	case	O
therapeutic	JJ	amod	O
angiogenesis	NN	nmod	O
is	VBZ	auxpass	O
discussed	VBN	ROOT	O
,	,	punct	O
together	RB	advmod	O
with	IN	prep	O
the	DT	det	O
most	RBS	advmod	O
recent	JJ	amod	O
results	NNS	pobj	O
from	IN	case	O
randomised	VBN	amod	O
trials	NNS	nmod	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
peripheral	JJ	amod	B-Multi-tissue_structure
arterial	JJ	amod	I-Multi-tissue_structure
disease	NN	nmod	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
shows	VBZ	ROOT	O
that	IN	mark	O
a	DT	det	O
mutant	NN	nsubj	O
with	IN	case	O
an	DT	det	O
LMP1	NN	compound	B-Gene_or_gene_product
site	NN	compound	O
-	:	punct	O
specific	JJ	amod	O
mutation	NN	nmod	O
at	IN	case	O
TES2	NN	nmod	O
,	,	punct	O
LMP1	NN	appos	B-Gene_or_gene_product
(	-LRB-	punct	O
TRADD	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
initially	RB	advmod	O
stimulates	VBZ	ccomp	O
cell	NN	compound	B-Cell
growth	NN	dobj	O
and	CC	cc	O
significantly	RB	advmod	O
extends	VBZ	conj	O
the	DT	det	O
life	NN	compound	O
span	NN	dobj	O
of	IN	case	O
MEF	NNP	nmod	B-Cell
.	.	punct	O

We	PRP	nsubj	O
previously	RB	advmod	O
reported	VBD	ROOT	O
that	IN	mark	O
a	DT	det	O
single	JJ	amod	O
dose	NN	nsubj	O
of	IN	case	O
ethanol	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
1	CD	dep	O
.	.	punct	O
4	CD	nummod	O
g	NN	dep	O
/	SYM	punct	O
kg	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
yielding	VBG	acl	O
a	DT	det	O
blood	NN	compound	B-Organism_substance
alcohol	NN	compound	B-Simple_chemical
concentration	NN	dobj	O
of	IN	case	O
100	CD	nummod	O
mg	NN	nmod	O
/	:	punct	O
dl	NN	appos	O
,	,	punct	O
significantly	RB	advmod	O
impairs	VBZ	ccomp	O
angiogenesis	NN	dobj	O
in	IN	case	O
murine	JJ	amod	B-Organism
wounds	NNS	nmod	B-Pathological_formation
,	,	punct	O
despite	IN	case	O
adequate	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
suggesting	VBG	advcl	O
direct	JJ	amod	O
effects	NNS	dobj	O
of	IN	case	O
ethanol	NN	nmod	B-Simple_chemical
on	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
signaling	NN	nmod	O
(	-LRB-	punct	O
40	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
A5	NN	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
will	MD	aux	O
be	VB	cop	O
a	DT	det	O
potent	JJ	amod	O
inhibitor	NN	ccomp	O
of	IN	case	O
neovascularization	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
will	MD	aux	O
demonstrate	VB	ROOT	O
here	RB	advmod	O
that	IN	mark	O
the	DT	det	O
level	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
natural	JJ	amod	O
ocular	JJ	amod	O
anti	JJ	compound	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
agent	NN	compound	O
PEDF	NN	nmod	B-Gene_or_gene_product
is	VBZ	auxpass	O
inversely	RB	advmod	O
associated	VBN	ccomp	O
with	IN	case	O
proliferative	JJ	amod	O
retinopathy	NN	nmod	O
.	.	punct	O

Quercetin	NNP	nsubj	B-Simple_chemical
increased	VBD	ROOT	O
the	DT	det	O
efficiency	NN	dobj	O
of	IN	mark	O
pumping	VBG	acl	O
in	IN	case	O
EAT	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
both	CC	cc:preconj	O
in	IN	case	O
the	DT	det	O
absence	NN	dobj	O
and	CC	cc	O
presence	NN	conj	O
of	IN	prep	O
the	DT	det	O
detergent	NN	pobj	O
.	.	punct	O

Molecular	JJ	amod	O
analyses	NNS	nsubj	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
in	IN	case	O
beclin	NN	compound	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
heterozygous	JJ	amod	O
mice	NNS	nmod	B-Organism
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
remaining	VBG	amod	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
allele	NN	nsubj	O
is	VBZ	cop	O
neither	CC	cc:preconj	O
mutated	VBN	ccomp	O
nor	CC	cc	O
silenced	VBN	conj	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
high	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
Ang	NN	compound	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
also	RB	advmod	O
promotes	VBZ	ROOT	O
rapid	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
capillary	JJ	amod	B-Tissue
diameter	NN	nmod	O
,	,	punct	O
remodeling	NN	advcl	O
of	IN	case	O
the	DT	det	O
basal	JJ	amod	B-Cellular_component
lamina	NN	nmod	I-Cellular_component
,	,	punct	O
proliferation	NN	conj	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
and	CC	cc	O
stimulates	VBZ	conj	O
sprouting	NN	dobj	O
of	IN	prep	O
new	JJ	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	pobj	I-Multi-tissue_structure
.	.	punct	O

METHODS	NNS	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
analyzed	VBD	ROOT	O
the	DT	det	O
hypermethylation	NN	compound	O
status	NN	dobj	O
and	CC	cc	O
expression	NN	conj	O
of	IN	case	O
the	DT	det	O
gene	NN	nmod	O
and	CC	cc	O
12q13	NN	conj	O
.	.	punct	O
1	CD	nummod	O
loss	NN	ROOT	O
of	IN	case	O
heterozygosity	NN	nmod	O
in	IN	case	O
31	CD	nummod	O
PCNSLs	NNS	nmod	B-Cancer
.	.	punct	O

We	PRP	nsubj	O
screened	VBD	ROOT	O
200	CD	nummod	O
RTK	NN	compound	O
target	NN	nmod:npmod	O
-	HYPH	punct	O
based	VBN	amod	O
compounds	NNS	dobj	O
and	CC	cc	O
identified	VBD	conj	O
one	CD	dobj	O
(	-LRB-	punct	O
TKI	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
31	CD	appos	I-Simple_chemical
)	-RRB-	punct	O
that	WDT	nsubj	O
potently	RB	advmod	O
inhibited	VBD	ccomp	O
VEGFR	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
kinase	NN	compound	O
activity	NN	dobj	O
(	-LRB-	punct	O
IC50	NN	nsubj	O
=	JJ	advcl	O
0	CD	dobj	O
.	.	punct	O
596	CD	nummod	O
microM	NN	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

Mutants	NNS	nsubj	O
of	IN	case	O
TEL	NN	nmod	B-Gene_or_gene_product
that	WDT	nsubj	O
removed	VBD	acl:relcl	O
a	DT	det	O
binding	VBG	amod	O
site	NN	dobj	O
for	IN	case	O
the	DT	det	O
mSin3A	NN	amod	B-Gene_or_gene_product
corepressor	NN	nmod	O
but	CC	cc	O
retained	VBD	conj	O
the	DT	det	O
ETS	NN	compound	O
domain	NN	nsubj	O
failed	VBD	ROOT	O
to	TO	mark	O
repress	VB	xcomp	O
stromelysin	NN	dobj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Highly	RB	advmod	O
metastatic	JJ	amod	O
tumors	NNS	nsubj	B-Cancer
with	IN	case	O
beta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
stabilization	NN	nmod	O
are	VBP	cop	O
very	RB	advmod	O
similar	JJ	ROOT	O
to	TO	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
melanomas	NNS	nmod	B-Cancer
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
insulin	NN	nmod	B-Gene_or_gene_product
on	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
was	VBD	auxpass	O
examined	VBN	dep	O
by	IN	case	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	compound	O
studies	NNS	nmod	O
of	IN	case	O
rat	NN	compound	B-Organism
retinal	JJ	amod	B-Multi-tissue_structure
VEGF	NN	compound	B-Gene_or_gene_product
transcripts	NNS	nmod	O
.	.	punct	O

Promoting	VBG	csubj	O
angiogenesis	NN	dobj	O
via	IN	case	O
delivery	NN	nmod	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
other	JJ	amod	O
angiogenic	JJ	amod	O
factors	NNS	conj	O
is	VBZ	cop	O
both	CC	cc:preconj	O
a	DT	det	O
potential	JJ	amod	O
therapy	NN	ROOT	O
for	IN	case	O
cardiovascular	JJ	amod	B-Anatomical_system
diseases	NNS	nmod	O
and	CC	cc	O
a	DT	det	O
critical	JJ	amod	O
aspect	NN	conj	O
for	IN	case	O
tissue	NN	compound	B-Tissue
regeneration	NN	nmod	O
.	.	punct	O

In	IN	case	O
down	RB	pcomp	O
modulated	VBN	amod	O
growing	VBG	amod	O
cells	NNS	nmod	B-Cell
,	,	punct	O
PDBu	NNS	nsubj	B-Simple_chemical
caused	VBD	ROOT	O
almost	RB	advmod	O
complete	JJ	amod	O
inhibition	NN	dobj	O
of	IN	case	O
EGF	NN	compound	B-Gene_or_gene_product
binding	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
in	IN	case	O
down	RB	amod	O
modulated	VBN	amod	O
stationary	JJ	amod	O
cells	NNS	nmod	B-Cell
,	,	punct	O
minimal	JJ	amod	O
inhibition	NN	nsubjpass	O
of	IN	case	O
EGF	NN	compound	B-Gene_or_gene_product
binding	NN	nmod	O
by	IN	case	O
PDBu	NN	nmod	B-Simple_chemical
was	VBD	auxpass	O
observed	VBN	parataxis	O
.	.	punct	O

Using	VBG	advcl	O
a	DT	det	O
construct	NN	dobj	O
containing	VBG	acl	O
the	DT	det	O
VEGF	NN	compound	B-Gene_or_gene_product
promoter	NN	dobj	O
linked	VBN	acl	O
to	TO	case	O
a	DT	det	O
luciferase	NN	compound	B-Gene_or_gene_product
reporter	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
a	DT	det	O
mutation	NN	nsubj	O
reducing	VBG	acl	O
HIF	NN	compound	B-Gene_or_gene_product
binding	NN	dobj	O
to	TO	case	O
the	DT	det	O
VEGF	NN	compound	B-Gene_or_gene_product
promoter	NN	nmod	O
had	VBD	ccomp	O
no	DT	neg	O
significant	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
luciferase	NN	compound	B-Gene_or_gene_product
production	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
M	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	compound	I-Gene_or_gene_product
stimulation	NN	nmod	O
.	.	punct	O

Suppressing	VBG	csubj	O
PTTG	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
by	IN	case	O
siRNA	NN	nmod	O
decreased	VBD	ROOT	O
cell	NN	compound	B-Cell
motility	NN	dobj	O
in	IN	case	O
both	CC	cc:preconj	O
PTTG	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
HA	NNP	compound	O
/	:	punct	O
EC9706	NN	nmod	O
and	CC	cc	O
KYSE150	NN	conj	B-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

One	CD	nummod	O
week	NN	npadvmod	O
later	RB	advmod	O
,	,	punct	O
IGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
transfected	VBN	amod	O
SMCs	NNS	nsubj	B-Cell
had	VBD	aux	O
increased	VBN	ROOT	O
myocardial	JJ	amod	B-Multi-tissue_structure
IGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
levels	NNS	dobj	O
,	,	punct	O
increased	VBN	amod	O
Bcl2	NN	compound	B-Gene_or_gene_product
expression	NN	conj	O
,	,	punct	O
limited	JJ	amod	O
cell	NN	compound	B-Cell
apoptosis	NN	conj	O
,	,	punct	O
and	CC	cc	O
enhanced	VBD	amod	O
vessel	NN	compound	B-Multi-tissue_structure
formation	NN	conj	O
in	IN	case	O
the	DT	det	O
myocardial	JJ	amod	B-Pathological_formation
scar	NN	nmod	I-Pathological_formation
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
two	CD	nummod	O
control	NN	compound	O
groups	NNS	advcl	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	advmod	O
than	IN	mwe	O
0	CD	dep	O
.	.	punct	O
05	CD	dep	O
for	IN	case	O
all	DT	det	O
groups	NNS	nmod	O
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
transcript	NN	ROOT	O
from	IN	case	O
the	DT	det	O
long	JJ	amod	B-Cellular_component
terminal	JJ	amod	I-Cellular_component
repeats	NNS	nmod	I-Cellular_component
of	IN	case	O
a	DT	det	O
murine	JJ	amod	B-Organism
retrovirus	NN	nmod	I-Organism
associated	VBN	acl	O
with	IN	case	O
trans	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
cellular	JJ	amod	B-Cell
genes	NNS	nmod	O
.	.	punct	O

Experiments	NNS	nsubj	O
with	IN	prep	O
nu	CC	advmod	B-Organism
/	SYM	punct	I-Organism
nu	PRP	amod	I-Organism
mice	NNS	conj	I-Organism
,	,	punct	O
nonobese	JJ	amod	B-Organism
diabetic	JJ	amod	I-Organism
-	HYPH	punct	I-Organism
SCID	NN	compound	I-Organism
mice	NNS	conj	I-Organism
,	,	punct	O
or	CC	cc	O
activated	VBN	ROOT	O
spc	NN	advmod	B-Cell
enriched	VBN	dobj	O
in	IN	case	O
specific	JJ	amod	O
cell	NN	compound	B-Cell
subpopulations	NNS	nmod	O
demonstrated	VBD	conj	O
that	IN	mark	O
CD4	NN	nsubjpass	B-Gene_or_gene_product
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
,	,	punct	O
CD8	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
NK	NN	compound	B-Cell
cells	NNS	conj	I-Cell
are	VBP	auxpass	O
all	DT	advmod	O
needed	VBN	ccomp	O
to	TO	mark	O
mediate	VB	xcomp	O
the	DT	det	O
full	JJ	amod	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenetic	JJ	amod	O
effect	NN	dobj	O
of	IN	case	O
IL	NN	nmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
12	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
betulin	NN	nsubj	B-Simple_chemical
significantly	RB	advmod	O
inhibited	VBD	ccomp	O
cell	NN	compound	B-Cell
viability	NN	dobj	O
in	IN	case	O
cervix	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
HeLa	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
hepatoma	NN	compound	B-Cell
HepG2	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
,	,	punct	O
lung	NN	compound	B-Cell
adenocarcinoma	NN	compound	I-Cell
A549	NN	compound	I-Cell
cells	NNS	conj	I-Cell
,	,	punct	O
and	CC	cc	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
MCF	NNP	compound	I-Cell
-	HYPH	punct	I-Cell
7	CD	nummod	I-Cell
cells	NNS	conj	I-Cell
with	IN	case	O
IC	NN	nmod	O
(	-LRB-	punct	O
50	CD	dep	O
)	-RRB-	punct	O
values	NNS	dobj	O
ranging	VBG	acl	O
from	IN	case	O
10	CD	compound	O
to	TO	dep	O
15	CD	nummod	O
microg	NN	compound	O
/	:	punct	O
mL	NN	nmod	O
.	.	punct	O

Hyperfibrinogenemia	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
lymphatic	JJ	nmod	B-Multi-tissue_structure
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
hematogenous	JJ	amod	O
metastasis	NN	conj	O
and	CC	cc	O
worse	JJR	conj	O
clinical	JJ	amod	O
outcome	NN	dobj	O
in	IN	case	O
T2	NN	compound	B-Cancer
gastric	JJ	amod	I-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Similar	JJ	amod	O
results	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
obtained	VBN	ROOT	O
with	IN	case	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
and	CC	cc	O
experimental	JJ	amod	O
animal	NN	compound	O
models	NNS	conj	O
.	.	punct	O

The	DT	det	O
primary	JJ	amod	O
results	NNS	nsubj	O
indicated	VBD	ROOT	O
(	-LRB-	punct	O
i	LS	dep	O
)	-RRB-	punct	O
positive	JJ	amod	O
results	NNS	nsubj	O
of	IN	case	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	nmod	O
are	VBP	cop	O
presence	NN	ccomp	O
of	IN	case	O
granules	NNS	nmod	B-Cellular_component
or	CC	cc	O
masses	NNS	conj	O
in	IN	case	O
the	DT	det	O
cytoplasm	NN	nmod	B-Organism_substance
;	:	punct	O
(	-LRB-	punct	O
ii	LS	dep	O
)	-RRB-	punct	O
the	DT	det	O
less	JJR	amod	O
expression	NN	dep	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
,	,	punct	O
the	DT	det	O
higher	JJR	amod	O
metastatic	JJ	amod	O
rate	NN	appos	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
hepatocellular	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	nummod	O
)	-RRB-	punct	O
;	:	punct	O
(	-LRB-	punct	O
iii	LS	dep	O
)	-RRB-	punct	O
expression	NN	nsubj	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
mRNA	NN	compound	O
dose	NN	nmod	O
not	RB	neg	O
correlate	VBP	parataxis	O
with	IN	case	O
some	DT	det	O
other	JJ	amod	O
factors	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
tumor	NN	compound	B-Cancer
size	NN	nmod	O
and	CC	cc	O
the	DT	det	O
background	NN	conj	O
of	IN	case	O
other	JJ	amod	O
liver	NN	compound	B-Organ
diseases	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
produced	VBD	ROOT	O
a	DT	det	O
transgenic	JJ	amod	O
mouse	NN	compound	B-Organism
line	NN	dobj	O
that	WDT	nsubj	O
expresses	VBZ	acl:relcl	O
simian	JJ	amod	B-Organism
virus	NN	compound	I-Organism
(	-LRB-	punct	O
SV40	NN	appos	B-Organism
)	-RRB-	punct	O
transforming	NN	amod	O
sequences	NNS	dobj	O
under	IN	case	O
control	NN	nmod	O
of	IN	case	O
the	DT	det	O
1	CD	nmod	O
.	.	punct	O
4	CD	nummod	O
kb	NN	compound	O
tyrosinase	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
related	JJ	amod	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
TRP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
promoter	NN	ROOT	O
,	,	punct	O
targeting	VBG	acl	O
expression	NN	dobj	O
of	IN	case	O
T	NN	compound	B-Gene_or_gene_product
antigen	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
Tag	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
to	TO	case	O
the	DT	det	O
RPE	NN	nmod	B-Tissue
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
UV	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
Erbb2	NN	compound	B-Gene_or_gene_product
activation	NN	nsubj	O
increases	VBZ	ROOT	O
skin	NN	compound	B-Organ
tumorigenesis	NN	dobj	O
through	IN	case	O
inhibitory	JJ	amod	O
phosphorylation	NN	nmod	O
of	IN	case	O
Chk1	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
Cdc25a	NN	compound	B-Gene_or_gene_product
maintenance	NN	conj	O
,	,	punct	O
and	CC	cc	O
suppression	NN	conj	O
of	IN	case	O
S	NN	compound	O
-	HYPH	punct	O
phase	NN	compound	O
arrest	NN	nmod	O
via	IN	case	O
a	DT	det	O
PI3K	NN	nmod:npmod	B-Gene_or_gene_product
/	:	punct	O
Akt	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
mechanism	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
cell	NN	compound	B-Cell
morphology	NN	nmod	O
on	IN	case	O
the	DT	det	O
migration	NN	nmod	O
of	IN	case	O
bovine	JJ	amod	B-Organism
aortic	JJ	amod	B-Cell
ECs	NNS	nmod	I-Cell
by	IN	mark	O
culturing	VBG	advcl	O
cells	NNS	dobj	B-Cell
on	IN	case	O
micropatterned	VBN	amod	O
strips	NNS	nmod	O
of	IN	case	O
collagen	NN	compound	B-Gene_or_gene_product
matrix	NN	nmod	B-Cellular_component
(	-LRB-	punct	O
60	CD	nummod	O
-	HYPH	punct	O
,	,	punct	O
30	CD	conj	O
-	HYPH	punct	O
,	,	punct	O
and	CC	cc	O
15	CD	nummod	O
-	HYPH	punct	O
microm	NN	dep	O
wide	JJ	amod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
inhibition	NN	nsubj	O
of	IN	case	O
fibrinolysis	NN	nmod	O
or	CC	cc	O
proteases	NNS	conj	O
decreased	VBD	ROOT	O
the	DT	det	O
primary	JJ	amod	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
and	CC	cc	O
pulmonary	JJ	amod	B-Organ
metastasis	NN	conj	O
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
activation	NN	nsubj	O
of	IN	case	O
fibrinolysis	NN	nmod	O
or	CC	cc	O
proteases	NNS	conj	O
increased	VBD	parataxis	O
the	DT	det	O
number	NN	dobj	O
of	IN	case	O
metastatic	JJ	amod	O
foci	NNS	nmod	O
in	IN	case	O
the	DT	det	O
lung	NN	nmod	B-Organ
.	.	punct	O

Dietary	NNP	amod	O
CLA	NNP	nsubj	B-Simple_chemical
decreased	VBD	ROOT	O
serum	NN	compound	B-Organism_substance
levels	NNS	dobj	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
whole	JJ	amod	O
mammary	JJ	amod	B-Organ
gland	NN	compound	I-Organ
levels	NNS	conj	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
its	PRP$	nmod:poss	O
receptor	NN	compound	O
Flk	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Domain	NN	nsubj	O
5	CD	nummod	O
(	-LRB-	punct	O
D5	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
cleaved	VBN	amod	O
high	JJ	amod	B-Gene_or_gene_product
molecular	JJ	amod	I-Gene_or_gene_product
weight	NN	compound	I-Gene_or_gene_product
kininogen	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
HKa	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
inhibits	VBZ	ROOT	O
angiogenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
and	CC	cc	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
cell	NN	compound	B-Cell
signaling	NN	compound	O
pathways	NNS	nsubjpass	O
involved	VBN	acl	O
in	IN	case	O
HKa	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
D5	NN	conj	O
inhibition	NN	nmod	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
are	VBP	auxpass	O
incompletely	RB	advmod	O
delineated	VBN	conj	O
.	.	punct	O

MPs	NNS	nsubj	B-Gene_or_gene_product
also	RB	advmod	O
play	VBP	ROOT	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
.	.	punct	O

PTTG	NN	compound	B-Gene_or_gene_product
overexpression	NN	nsubj	O
promotes	VBZ	ROOT	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
esophageal	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

Treatment	NN	nsubj	O
with	IN	case	O
tunicamycin	NN	nmod	B-Simple_chemical
produced	VBD	ROOT	O
a	DT	det	O
40	CD	compound	O
-	HYPH	punct	O
50	CD	nummod	O
%	NN	amod	O
inhibition	NN	dobj	O
of	IN	case	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
deoxyglucose	NN	compound	I-Simple_chemical
uptake	NN	nmod	O
and	CC	cc	O
this	DT	nsubjpass	O
was	VBD	auxpass	O
associated	VBN	conj	O
with	IN	case	O
a	DT	det	O
2	CD	compound	O
-	SYM	punct	O
2	CD	nummod	O
.	.	punct	O
5	CD	meta	O
-	HYPH	punct	O
fold	JJ	dep	O
decrease	NN	nmod	O
in	IN	case	O
transporter	NN	compound	O
affinity	NN	nmod	O
for	IN	case	O
glucose	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
Km	NN	appos	O
)	-RRB-	punct	O
without	IN	case	O
a	DT	det	O
change	NN	nmod	O
in	IN	case	O
Vmax	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	nsubjpass	I-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
are	VBP	auxpass	O
increased	VBN	ccomp	O
through	IN	case	O
A3	NN	compound	B-Gene_or_gene_product
adenosine	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
stimulation	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
effects	NNS	nsubjpass	O
on	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
8	CD	nmod	I-Gene_or_gene_product
are	VBP	auxpass	O
mediated	VBN	parataxis	O
via	IN	case	O
the	DT	det	O
A2B	NN	compound	B-Gene_or_gene_product
subtype	NN	nmod	O
.	.	punct	O

Chronic	JJ	amod	O
wounds	NNS	nsubj	B-Pathological_formation
are	VBP	ROOT	O
a	DT	det	O
major	JJ	amod	O
secondary	JJ	amod	O
complication	NN	attr	O
for	IN	prep	O
many	JJ	amod	O
people	NNS	pobj	B-Organism
with	IN	prep	O
impaired	JJ	amod	O
mobility	NN	pobj	O
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
Insulin	NN	nsubj	B-Gene_or_gene_product
increased	VBD	ROOT	O
VEGF	NN	compound	B-Gene_or_gene_product
mRNA	NN	compound	O
levels	NNS	dobj	O
in	IN	case	O
the	DT	det	O
ganglion	NN	nmod	B-Tissue
,	,	punct	O
inner	JJ	amod	B-Tissue
nuclear	JJ	conj	I-Tissue
,	,	punct	O
and	CC	cc	O
RPE	NN	compound	B-Tissue
cell	NN	compound	I-Tissue
layers	NNS	conj	I-Tissue
.	.	punct	O

Of	IN	case	O
the	DT	det	O
14	CD	nummod	O
tumors	NNS	nsubj	B-Cancer
that	WDT	nsubj	O
expressed	VBD	acl:relcl	O
CD40	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
all	DT	appos	O
but	CC	cc	O
1	CD	conj	O
(	-LRB-	punct	O
93	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
had	VBD	ROOT	O
either	CC	cc:preconj	O
nodal	JJ	dobj	B-Multi-tissue_structure
or	CC	cc	O
systemic	JJ	conj	O
metastasis	NN	dep	O
at	IN	case	O
the	DT	det	O
time	NN	nmod	O
of	IN	case	O
diagnosis	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
EPOX	NN	nsubj	B-Simple_chemical
is	VBZ	cop	O
a	DT	det	O
novel	JJ	amod	O
antiangiogenic	JJ	amod	O
agent	NN	ccomp	O
,	,	punct	O
making	VBG	xcomp	O
it	PRP	nsubj	O
a	DT	det	O
promising	JJ	amod	O
lead	NN	amod	O
compound	NN	ccomp	O
for	IN	case	O
further	JJ	amod	O
development	NN	nmod	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
pathologies	NNS	nmod	O
.	.	punct	O

These	DT	det	O
events	NNS	nsubjpass	O
are	VBP	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
short	JJ	amod	O
survival	NN	nmod	O
and	CC	cc	O
support	VBP	conj	O
the	DT	det	O
concept	NN	dobj	O
of	IN	case	O
a	DT	det	O
cooperative	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
BCR	NN	compound	B-Gene_or_gene_product
-	:	punct	O
ABL	NN	nmod	B-Gene_or_gene_product
with	IN	case	O
molecular	JJ	amod	O
RUNX1	NN	compound	B-Gene_or_gene_product
abnormalities	NNS	nmod	O
on	IN	case	O
the	DT	det	O
differentiation	NN	compound	O
arrest	NN	compound	O
phenotype	NN	nmod	O
observed	VBN	acl	O
during	IN	case	O
progression	NN	nmod	O
of	IN	case	O
CML	NN	nmod	B-Cancer
and	CC	cc	O
in	IN	case	O
BCR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
ABL	NN	conj	B-Gene_or_gene_product
+	CC	cc	O
ALL	NN	conj	O
.	.	punct	O

Mitochondrial	JJ	amod	B-Cellular_component
complex	NN	nsubj	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
or	CC	cc	O
succinate	JJ	amod	B-Gene_or_gene_product
dehydrogenase	NN	conj	I-Gene_or_gene_product
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
key	JJ	amod	O
enzymatic	JJ	amod	O
complex	NN	ROOT	O
involved	VBN	acl	O
in	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
tricarboxylic	JJ	amod	B-Simple_chemical
acid	NN	compound	I-Simple_chemical
(	-LRB-	punct	O
TCA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
cycle	NN	nmod	O
and	CC	cc	O
oxidative	JJ	amod	O
phosphorylation	NN	conj	O
as	IN	case	O
part	NN	nmod	O
of	IN	case	O
the	DT	det	O
mitochondrial	JJ	amod	B-Cellular_component
respiratory	JJ	amod	O
chain	NN	nmod	O
.	.	punct	O

[	-LRB-	punct	O
Photodynamic	JJ	amod	O
therapy	NN	ROOT	O
in	IN	case	O
severe	JJ	amod	O
chronic	JJ	amod	O
central	JJ	amod	O
serous	JJ	amod	B-Organism_substance
chorioretinopaty	NN	nmod	O
]	-RRB-	punct	O

Our	PRP$	poss	O
objectives	NNS	nsubj	O
were	VBD	ROOT	O
to	TO	aux	O
determine	VB	xcomp	O
the	DT	det	O
safety	NN	dobj	O
and	CC	cc	O
efficacy	NN	conj	O
of	IN	case	O
rofecoxib	JJ	nmod	B-Simple_chemical
in	IN	mark	O
treating	VBG	advcl	O
acute	JJ	amod	O
haemarthrosis	NN	dobj	O
,	,	punct	O
chronic	JJ	amod	O
synovitis	NN	conj	O
,	,	punct	O
target	NN	compound	O
joints	NNS	conj	B-Multi-tissue_structure
and	CC	cc	O
pain	NN	conj	O
.	.	punct	O

This	DT	det	O
metastatic	JJ	amod	O
ability	NN	nsubjpass	O
was	VBD	auxpass	O
enhanced	VBN	ROOT	O
remarkably	RB	advmod	O
after	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
(	-LRB-	punct	O
subcutaneous	JJ	amod	O
tumor	NN	compound	B-Cancer
formation	NN	dep	O
in	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
)	-RRB-	punct	O
accompanied	VBN	acl	O
by	IN	case	O
increased	VBN	amod	O
mRNA	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
gene	NN	compound	O
amplification	NN	conj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
-	HYPH	punct	O
derived	VBN	amod	O
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
oncogene	NN	nmod	O
,	,	punct	O
while	IN	mark	O
it	PRP	nsubj	O
declined	VBD	advcl	O
gradually	RB	advmod	O
as	IN	mark	O
the	DT	det	O
passage	NN	compound	O
number	NN	nsubj	O
increased	VBD	advcl	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
with	IN	case	O
corresponding	JJ	amod	O
decreases	NNS	nmod	O
of	IN	case	O
gene	NN	compound	O
amplification	NN	nmod	O
and	CC	cc	O
mRNA	NN	compound	O
expression	NN	conj	O
.	.	punct	O

METHODS	NNS	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
quantified	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
MCT	NN	compound	B-Gene_or_gene_product
isoforms	NNS	nmod	O
in	IN	case	O
human	JJ	amod	B-Organism
glioblastoma	NN	compound	B-Cell
multiforme	NN	nmod	I-Cell
and	CC	cc	O
glioma	NN	nmod:npmod	B-Cell
-	HYPH	punct	I-Cell
derived	VBN	amod	I-Cell
cells	NNS	compound	I-Cell
lines	NNS	conj	I-Cell
by	IN	case	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

SWAP	NNP	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
70	CD	nummod	I-Gene_or_gene_product
is	VBZ	ROOT	O
a	DT	det	O
phosphatidylinositol	NN	compound	B-Simple_chemical
trisphosphate	NN	compound	I-Simple_chemical
(	-LRB-	punct	O
PtdIns	NN	compound	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
3	CD	dep	I-Simple_chemical
,	,	punct	I-Simple_chemical
4	CD	conj	I-Simple_chemical
,	,	punct	I-Simple_chemical
5	LS	dep	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
P	NN	compound	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
3	CD	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
)	-RRB-	punct	O
binding	NN	compound	O
protein	NN	attr	O
,	,	punct	O
which	WDT	nsubj	O
acts	VBZ	acl:relcl	O
in	IN	case	O
F	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
actin	NN	compound	I-Gene_or_gene_product
rearrangement	NN	nmod	O
.	.	punct	O

The	DT	det	O
transformation	NN	nsubj	O
of	IN	case	O
normal	JJ	amod	O
melanocytes	NNS	nmod	B-Cell
,	,	punct	O
or	CC	cc	O
melanocyte	NN	compound	B-Cell
stem	NN	compound	I-Cell
cells	NNS	conj	I-Cell
,	,	punct	O
to	TO	case	O
melanoma	NN	nmod	B-Cancer
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
complex	JJ	amod	O
process	NN	ROOT	O
involving	VBG	acl	O
multiple	JJ	amod	O
mechanisms	NNS	dobj	O
.	.	punct	O

Topo	IN	compound	B-Gene_or_gene_product
I	NN	compound	I-Gene_or_gene_product
expression	NN	nsubjpass	O
in	IN	case	O
paired	JJ	amod	O
primary	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
for	IN	case	O
concordance	NN	nmod	O
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
might	MD	aux	O
support	VB	appos	O
the	DT	det	O
idea	NN	dobj	O
that	IN	mark	O
hyperfibrinogenemia	NN	nsubj	O
can	MD	aux	O
augment	VB	ccomp	O
lymphatic	JJ	amod	B-Cell
and	CC	cc	O
hematogeneous	JJ	conj	O
metastasis	NN	dobj	O
of	IN	case	O
advanced	JJ	amod	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
major	JJ	amod	O
determinant	NN	acl:relcl	O
of	IN	case	O
the	DT	det	O
prognosis	NN	nmod	O
in	IN	case	O
T2	NN	compound	B-Cancer
gastric	JJ	amod	I-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

As	IN	case	O
a	DT	det	O
consequence	NN	nmod	O
,	,	punct	O
these	DT	det	O
tumors	NNS	nsubj	B-Cancer
generate	VBP	ROOT	O
more	JJR	amod	O
lactate	NN	dobj	B-Simple_chemical
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
effluxed	VBN	acl:relcl	O
from	IN	case	O
cells	NNS	nmod	B-Cell
by	IN	case	O
monocarboxylate	JJ	amod	B-Gene_or_gene_product
transporters	NNS	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
MCTs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
parallel	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
assessed	VBD	ROOT	O
several	JJ	amod	O
human	JJ	amod	B-Organism
melanoma	NN	compound	B-Tissue
biopsy	NN	compound	I-Tissue
samples	NNS	dobj	I-Tissue
and	CC	cc	O
found	VBN	conj	O
again	RB	advmod	O
that	IN	mark	O
AKT2	NN	nsubj	B-Gene_or_gene_product
was	VBD	cop	O
the	DT	det	O
predominantly	RB	advmod	O
activated	VBN	amod	O
AKT	NN	ccomp	B-Gene_or_gene_product
in	IN	case	O
these	DT	det	O
human	JJ	amod	B-Organism
melanoma	NN	compound	B-Tissue
biopsies	NNS	nmod	I-Tissue
.	.	punct	O

In	IN	case	O
the	DT	det	O
current	JJ	amod	O
report	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
tested	VBD	ROOT	O
the	DT	det	O
sensitivity	NN	dobj	O
of	IN	case	O
the	DT	det	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
overexpressing	VBG	amod	O
cells	NNS	nmod	O
(	-LRB-	punct	O
Rat	NN	compound	O
6	CD	nummod	O
/	:	punct	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
to	IN	case	O
two	CD	nummod	O
additional	JJ	amod	O
chemicals	NNS	nmod	O
:	:	punct	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
azacytidine	NN	dep	I-Simple_chemical
and	CC	cc	O
MnSO4	NN	conj	B-Simple_chemical
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Primary	JJ	amod	B-Cancer
lung	NN	compound	I-Cancer
cancers	NNS	nsubjpass	I-Cancer
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
269	CD	dep	O
)	-RRB-	punct	O
and	CC	cc	O
non	JJ	amod	B-Tissue
neoplastic	JJ	amod	I-Tissue
lung	NN	compound	I-Tissue
tissue	NN	conj	I-Tissue
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
35	CD	dep	O
)	-RRB-	punct	O
were	VBD	auxpass	O
tested	VBN	dep	O
for	IN	case	O
LDH5	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
using	VBG	xcomp	O
a	DT	det	O
polyclonal	JJ	amod	O
LDH5	NN	compound	B-Gene_or_gene_product
antibody	NN	dobj	O
(	-LRB-	punct	O
ab53010	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

ELISA	NN	nsubj	O
found	VBD	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factors	NNS	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
both	CC	cc:preconj	O
in	IN	case	O
the	DT	det	O
tested	VBN	amod	O
oral	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
NOK	NN	conj	B-Cell
.	.	punct	O

Little	JJ	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
about	IN	case	O
the	DT	det	O
specificity	NN	nmod	O
of	IN	case	O
angiogenic	JJ	amod	O
properties	NNS	nmod	O
of	IN	case	O
oral	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
the	DT	det	O
possible	JJ	amod	O
mechanisms	NNS	conj	O
.	.	punct	O

Because	IN	prep	O
of	IN	pcomp	O
this	DT	pobj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
virtual	JJ	amod	O
explosion	NN	pobj	O
of	IN	prep	O
interest	NN	pobj	O
in	IN	prep	O
pomegranate	NN	pobj	B-Organism
as	IN	prep	O
a	DT	det	O
medicinal	JJ	amod	O
and	CC	cc	O
nutritional	JJ	conj	O
product	NN	pobj	O
that	WDT	nsubj	O
has	VBZ	aux	O
followed	VBN	relcl	O
,	,	punct	O
this	DT	det	O
review	NN	nsubjpass	O
is	VBZ	auxpass	O
accordingly	RB	advmod	O
launched	VBN	ROOT	O
.	.	punct	O

Therapeutic	JJ	amod	O
Electromagnetic	NNP	compound	O
Field	NNP	ROOT	O
(	-LRB-	punct	O
TEMF	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
gamma	NN	compound	O
irradiation	NN	conj	O
on	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
xenograft	NN	compound	I-Cancer
growth	NN	nmod	O
,	,	punct	O
angiogenesis	NN	conj	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

The	DT	det	O
initial	JJ	amod	O
step	NN	nsubjpass	O
of	IN	case	O
adhesion	NN	nmod	O
was	VBD	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
sialyl	JJ	compound	B-Simple_chemical
Lewis	NNP	nmod	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
x	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
(	-LRB-	punct	O
Le	NN	dep	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
x	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
sialyl	VBD	compound	B-Simple_chemical
Le	NN	conj	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
a	DT	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
,	,	punct	O
the	DT	det	O
carbohydrate	NN	amod	O
determinants	NNS	appos	O
expressed	VBN	acl	O
on	IN	case	O
the	DT	det	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
and	CC	cc	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
selectin	NN	conj	I-Gene_or_gene_product
expressed	VBN	acl	O
constitutively	RB	advmod	O
on	IN	case	O
F	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
2	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

After	IN	case	O
1	CD	nummod	O
week	NN	nmod	O
of	IN	case	O
treatment	NN	nmod	O
,	,	punct	O
before	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
capillary	JJ	amod	B-Tissue
length	NN	compound	O
density	NN	nmod	O
,	,	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
mRNA	NN	nsubj	O
increased	VBD	ROOT	O
greater	JJR	advmod	O
than	IN	case	O
2	CD	nummod	O
-	HYPH	punct	O
fold	NN	nmod	O
and	CC	cc	O
then	RB	advmod	O
declined	VBD	conj	O
to	TO	mark	O
control	VB	xcomp	O
levels	NNS	dobj	O
after	IN	case	O
3	CD	nummod	O
weeks	NNS	nmod	O
of	IN	case	O
treatment	NN	nmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
confirm	VBP	ROOT	O
that	IN	mark	O
cellular	JJ	amod	B-Cell
immunity	NN	nsubjpass	O
is	VBZ	auxpass	O
significantly	RB	advmod	O
stimulated	VBN	ccomp	O
by	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nmod	I-Gene_or_gene_product
only	RB	advmod	O
during	IN	case	O
clinical	JJ	amod	O
benefit	NN	nmod	O
.	.	punct	O

No	DT	neg	O
AP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
19	CD	nummod	O
weeks	NNS	nmod	O
after	IN	case	O
initiation	NN	dep	O
.	.	punct	O

Betulin	NN	nsubj	B-Simple_chemical
(	-LRB-	punct	O
10	CD	nummod	O
microg	NN	compound	O
/	:	punct	O
mL	NN	appos	O
)	-RRB-	punct	O
induces	VBZ	ROOT	O
apoptotic	JJ	amod	O
cell	NN	compound	B-Cell
death	NN	dobj	O
,	,	punct	O
as	IN	mark	O
evidenced	VBN	advcl	O
by	IN	case	O
morphological	JJ	amod	O
characteristics	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
membrane	NN	compound	B-Cellular_component
phosphatidylserine	NN	compound	B-Amino_acid
translocation	NN	nmod	O
,	,	punct	O
nuclear	JJ	amod	B-Cellular_component
condensation	NN	compound	O
/	:	punct	O
fragmentation	NN	conj	O
,	,	punct	O
and	CC	cc	O
apoptotic	JJ	amod	B-Cellular_component
body	NN	compound	I-Cellular_component
formation	NN	conj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
PECAM	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
promoted	VBD	ROOT	O
filopodia	NN	compound	B-Cellular_component
formation	NN	dobj	O
and	CC	cc	O
increased	VBD	conj	O
the	DT	det	O
protein	NN	compound	O
expression	NN	compound	O
levels	NNS	dobj	O
of	IN	case	O
Cdc42	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
Rho	NN	compound	B-Gene_or_gene_product
GTPase	NN	appos	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	acl:relcl	O
to	TO	mark	O
promote	VB	xcomp	O
the	DT	det	O
formation	NN	dobj	O
of	IN	prep	O
filopodia	NN	pobj	B-Cellular_component
.	.	punct	O

When	WRB	advmod	O
injected	VBN	advcl	O
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
xenografts	NNS	dep	I-Cancer
,	,	punct	O
pAd	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
T34A	NN	nsubj	I-Gene_or_gene_product
inhibited	VBD	ROOT	O
growth	NN	dobj	O
of	IN	case	O
established	JJ	amod	O
tumors	NNS	nmod	B-Cancer
and	CC	cc	O
triggered	VBD	conj	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
apoptosis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Epstein	NN	compound	B-Organism
-	HYPH	punct	I-Organism
Barr	NN	compound	I-Organism
virus	NN	nsubj	I-Organism
(	-LRB-	punct	O
EBV	NN	appos	B-Organism
)	-RRB-	punct	O
transforms	VBZ	ROOT	O
B	NN	compound	B-Cell
lymphocytes	NNS	dobj	I-Cell
through	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
latent	JJ	amod	O
viral	JJ	amod	O
proteins	NNS	nmod	O
EBNA	NN	dep	B-Gene_or_gene_product
and	CC	cc	O
latent	JJ	amod	B-Gene_or_gene_product
membrane	NN	compound	I-Gene_or_gene_product
protein	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
LMP	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

Morphogenesis	NN	ROOT	O
of	IN	case	O
embryonic	JJ	amod	B-Multi-tissue_structure
CNS	NN	compound	I-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

Cells	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
treated	VBN	ROOT	O
with	IN	case	O
curcumin	NN	nmod	B-Simple_chemical
and	CC	cc	O
examined	VBN	conj	O
for	IN	case	O
cell	NN	compound	B-Cell
viability	NN	nmod	O
by	IN	case	O
MTT	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
next	RB	advmod	O
examined	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
DMI	NN	nmod	B-Simple_chemical
on	IN	case	O
Ca3	NN	compound	B-Cell
/	SYM	punct	I-Cell
7	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
resistant	JJ	amod	O
to	TO	case	O
growth	NN	compound	O
inhibition	NN	nmod	O
by	IN	case	O
the	DT	det	O
synthetic	JJ	amod	O
glucocorticoid	NN	compound	B-Simple_chemical
fluocinolone	NN	compound	I-Simple_chemical
acetonide	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
FA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

Adenomatoid	JJ	amod	B-Cancer
tumour	NN	ROOT	I-Cancer
of	IN	case	O
the	DT	det	O
liver	NN	nmod	B-Organ
.	.	punct	O

Cells	NNS	nsubj	B-Cell
cannot	NN	advmod	O
survive	NN	ROOT	O
extended	VBD	xcomp	O
severe	JJ	amod	O
ischemia	NN	dobj	O
but	CC	cc	O
may	MD	aux	O
be	VB	cop	O
able	JJ	conj	O
to	TO	mark	O
adapt	VB	xcomp	O
to	IN	case	O
a	DT	det	O
moderate	JJ	amod	O
condition	NN	nmod	O
where	WRB	advmod	O
diffusion	NN	nsubj	O
to	TO	dep	O
and	CC	cc	O
from	IN	mark	O
bordering	VBG	conj	O
nonischemic	JJ	amod	O
regions	NNS	compound	O
sustains	VBZ	acl:relcl	O
vital	JJ	amod	O
functions	NNS	dobj	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
suppose	VBP	ROOT	O
that	DT	mark	O
knowledge	NN	nsubj	O
about	IN	case	O
heterogeneity	NN	nmod	O
between	IN	case	O
primary	JJ	nmod	O
and	CC	cc	O
metastatic	JJ	conj	O
tumor	NN	dep	B-Cancer
might	MD	aux	O
help	VB	ccomp	O
to	TO	mark	O
understand	VB	xcomp	O
mechanisms	NNS	dobj	O
of	IN	case	O
oral	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
progression	NN	nmod	O
.	.	punct	O

1	LS	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Tetradecylpyrrolidine	NN	compound	I-Simple_chemical
N	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
oxide	NN	nsubj	I-Simple_chemical
(	-LRB-	punct	O
TPNO	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
one	CD	appos	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
active	JJ	amod	O
compounds	NNS	nmod	O
,	,	punct	O
immediately	RB	advmod	O
after	IN	case	O
addition	NN	appos	O
to	TO	case	O
the	DT	det	O
suspension	NN	nmod	O
of	IN	case	O
Ehrlich	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
an	DT	det	O
ice	NN	compound	O
bath	NN	nmod	O
,	,	punct	O
decreased	VBD	ROOT	O
the	DT	det	O
level	NN	dobj	O
of	IN	case	O
ATP	NN	nmod	B-Simple_chemical
to	TO	case	O
the	DT	det	O
same	JJ	amod	O
extent	NN	nmod	O
over	IN	case	O
the	DT	det	O
whole	JJ	amod	O
concentration	NN	compound	O
range	NN	nmod	O
.	.	punct	O

The	DT	det	O
mice	NNS	nsubj	B-Organism
that	WDT	nsubj	O
received	VBD	acl:relcl	O
Hoxa9	NN	compound	B-Gene_or_gene_product
/	:	punct	O
Meis1	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
transduced	VBN	amod	O
bone	NN	compound	B-Cell
marrow	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
developed	VBD	ROOT	O
acute	JJ	amod	B-Cancer
myeloid	JJ	amod	I-Cancer
leukemia	NN	dobj	I-Cancer
(	-LRB-	punct	O
AML	NN	appos	B-Cancer
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
Trib1	NN	conj	B-Gene_or_gene_product
,	,	punct	O
Evi1	NN	conj	B-Gene_or_gene_product
,	,	punct	O
Ahi1	NN	conj	B-Gene_or_gene_product
,	,	punct	O
Raralpha	NN	conj	B-Gene_or_gene_product
,	,	punct	O
Pitpnb	NNP	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
AK039950	NN	nsubjpass	B-Gene_or_gene_product
were	VBD	auxpass	O
identified	VBN	conj	O
as	IN	case	O
candidate	NN	compound	O
cooperative	JJ	amod	O
genes	NNS	nmod	O
located	JJ	amod	O
near	IN	case	O
common	JJ	amod	O
retroviral	JJ	amod	O
integration	NN	compound	O
sites	NNS	nmod	O
.	.	punct	O

To	TO	mark	O
confirm	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
lymphangiogenesis	NN	nmod	O
in	IN	mark	O
mediating	VBG	advcl	O
metastasis	NN	dobj	O
,	,	punct	O
the	DT	det	O
low	JJ	amod	O
-	HYPH	punct	O
metastatic	JJ	amod	O
LAPC	NN	compound	B-Cell
-	:	punct	I-Cell
9	CD	nummod	I-Cell
tumor	NN	compound	I-Cell
cells	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
engineered	VBN	ROOT	O
to	TO	mark	O
overexpress	VB	xcomp	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
C	NNP	dobj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
the	DT	det	O
development	NN	nsubjpass	O
of	IN	case	O
metastases	NNS	nmod	B-Cancer
was	VBD	auxpass	O
evaluated	VBN	conj	O
.	.	punct	O

The	DT	det	O
mechanism	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
potent	JJ	amod	O
collaboration	NN	nmod	O
is	VBZ	auxpass	O
elucidated	VBN	ROOT	O
in	IN	case	O
this	DT	det	O
study	NN	nmod	O
of	IN	case	O
Runx2	NN	compound	B-Gene_or_gene_product
/	:	punct	O
MYC	NN	compound	B-Gene_or_gene_product
mice	NNS	nmod	O
.	.	punct	O

Vascularization	NN	nsubjpass	O
of	IN	case	O
subcutaneous	JJ	amod	O
Matrigel	NNP	compound	O
implants	VBZ	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	conj	O
were	VBD	auxpass	O
both	DT	cc:preconj	O
inhibited	VBN	ROOT	O
in	IN	case	O
PECAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
null	JJ	amod	O
mice	NNS	dobj	O
.	.	punct	O

RAF265	NN	nsubjpass	B-Simple_chemical
,	,	punct	O
a	DT	det	O
novel	JJ	amod	O
B	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Raf	NNP	compound	I-Gene_or_gene_product
/	:	punct	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
inhibitor	NN	appos	O
,	,	punct	O
was	VBD	auxpass	O
evaluated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
preclinical	JJ	amod	O
setting	NN	nmod	O
for	IN	case	O
its	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
inhibit	VB	acl	O
the	DT	det	O
uptake	NN	dobj	O
of	IN	case	O
PET	NN	compound	O
tracers	NNS	nmod	O
in	IN	case	O
the	DT	det	O
A375M	NN	compound	O
(	-LRB-	punct	O
B	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Raf	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
V600E	NN	appos	O
)	-RRB-	punct	O
)	-RRB-	punct	O
human	JJ	amod	O
melanoma	NN	compound	O
cell	NN	compound	O
line	NN	nmod	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
The	DT	det	O
anabolic	JJ	amod	O
properties	NNS	nsubjpass	O
of	IN	case	O
insulin	NN	nmod	B-Gene_or_gene_product
have	VBP	aux	O
been	VBN	auxpass	O
suggested	VBN	appos	O
for	IN	case	O
use	NN	nmod	O
to	TO	mark	O
reverse	VB	acl	O
malnutrition	NN	dobj	O
associated	VBN	acl	O
with	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
lower	JJR	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
density	NN	nsubj	O
found	VBN	acl	O
in	IN	case	O
the	DT	det	O
patients	NNS	nmod	B-Organism
with	IN	case	O
1	CD	nummod	O
mm	NN	nmod	O
/	,	punct	O
day	NN	compound	O
distraction	NN	compound	O
rate	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
related	JJ	ccomp	O
to	TO	case	O
disruption	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
the	DT	det	O
soft	JJ	amod	B-Tissue
connective	JJ	amod	I-Tissue
tissue	NN	nmod	I-Tissue
of	IN	case	O
the	DT	det	O
gap	NN	nmod	O
or	CC	cc	O
to	TO	case	O
a	DT	det	O
less	RBR	advmod	O
optimal	JJ	amod	O
mechanical	JJ	amod	O
stimulation	NN	conj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
involved	VBN	acl	O
in	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
only	RB	advmod	O
one	CD	nummod	O
prior	JJ	amod	O
report	NN	attr	O
describing	VBG	acl	O
rofecoxib	JJ	compound	B-Simple_chemical
treatment	NN	dobj	O
in	IN	case	O
a	DT	det	O
single	JJ	amod	O
haemophilia	NN	compound	O
patient	NN	nmod	B-Organism
.	.	punct	O

Among	IN	case	O
the	DT	det	O
most	RBS	advmod	O
potent	JJ	nsubj	O
of	IN	case	O
the	DT	det	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
is	VBZ	cop	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	ROOT	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
mechanism	NN	nsubjpass	O
by	IN	case	O
which	WDT	nmod	O
Notch	NN	compound	B-Gene_or_gene_product
oncoproteins	NNS	nsubj	O
(	-LRB-	punct	O
generically	RB	advmod	O
termed	VBN	acl	O
here	RB	advmod	O
as	IN	case	O
N	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
ic	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
)	-RRB-	punct	O
induce	VBP	acl:relcl	O
neoplastic	JJ	amod	O
transformation	NN	dobj	O
is	VBZ	auxpass	O
not	RB	neg	O
known	VBN	ROOT	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
targeted	VBD	ROOT	O
M2	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
PK	NN	dobj	I-Gene_or_gene_product
by	IN	case	O
synthetic	JJ	amod	O
peptide	NN	compound	O
aptamers	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
specifically	RB	advmod	O
bind	VBP	acl:relcl	O
to	TO	case	O
M2	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
PK	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
shift	VB	conj	O
the	DT	det	O
isoenzyme	NN	dobj	O
into	IN	case	O
its	PRP$	nmod:poss	O
low	JJ	amod	O
affinity	NN	compound	O
dimeric	JJ	amod	O
conformation	NN	nmod	O
.	.	punct	O

Previous	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
v	NN	det	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
erbA	NN	compound	I-Gene_or_gene_product
and	CC	cc	O
v	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myb	NN	nsubj	I-Gene_or_gene_product
can	MD	aux	O
induce	VB	ccomp	O
the	DT	det	O
proliferation	NN	dobj	O
of	IN	case	O
avian	JJ	amod	O
erythroid	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
culture	NN	nmod	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
investigate	VB	dep	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
PTEN	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
loss	NN	conj	O
of	IN	case	O
heterozygosity	NN	nmod	O
(	-LRB-	punct	O
LOH	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
its	PRP$	nmod:poss	O
epigenetic	JJ	amod	O
microsatellite	NN	nmod	O
in	IN	case	O
gastric	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
and	CC	cc	O
explore	VBP	conj	O
their	PRP$	nmod:poss	O
roles	NNS	dobj	O
in	IN	case	O
progression	NN	nmod	O
of	IN	case	O
gastric	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

Leukocyte	NN	compound	B-Cell
-	HYPH	punct	O
vessel	NN	compound	B-Multi-tissue_structure
wall	NN	compound	I-Multi-tissue_structure
interactions	NNS	nsubjpass	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
both	CC	cc:preconj	O
within	IN	nmod	O
and	CC	cc	O
outside	IN	conj	O
small	JJ	amod	O
tumors	NNS	nmod	B-Cancer
growing	VBG	acl	O
in	IN	prep	O
the	DT	det	O
ear	NN	pobj	B-Organ
,	,	punct	O
and	CC	cc	O
in	IN	case	O
ear	NN	amod	B-Tissue
microvessels	NNS	conj	I-Tissue
of	IN	case	O
mice	NNS	nmod	B-Organism
with	IN	case	O
a	DT	det	O
large	JJ	amod	O
tumor	NN	nmod	B-Cancer
growing	VBG	acl	O
on	IN	prep	O
their	PRP$	poss	O
flank	NN	pobj	B-Organism_subdivision
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
detected	VBD	ROOT	O
only	RB	advmod	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
nm23	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
and	CC	cc	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H2	NN	conj	I-Gene_or_gene_product
mRNA	NN	dobj	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
the	DT	det	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	nsubjpass	I-Multi-tissue_structure
close	RB	amod	O
to	IN	case	O
the	DT	det	O
salivary	JJ	amod	B-Organ
glands	NNS	nmod	I-Organ
were	VBD	auxpass	O
enlarged	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
histology	NN	nsubj	O
showed	VBD	conj	O
that	IN	mark	O
they	PRP	nsubj	O
had	VBD	ccomp	O
activated	VBN	amod	O
follicles	NNS	dobj	B-Multi-tissue_structure
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Both	CC	cc:preconj	O
SAT	NN	nsubj	B-Tissue
and	CC	cc	O
VAT	NN	conj	B-Tissue
expressed	VBD	dep	O
angiogenic	JJ	amod	O
factors	NNS	dobj	O
without	IN	case	O
significant	JJ	amod	O
difference	NN	nmod	O
for	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
expression	NN	nmod	O
.	.	punct	O

In	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
insulin	NN	nsubj	B-Gene_or_gene_product
increased	VBD	ROOT	O
VEGF	NN	compound	B-Gene_or_gene_product
mRNA	NN	compound	O
levels	NNS	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
RPE	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
enhanced	VBN	conj	O
VEGF	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
activity	NN	dobj	O
without	IN	mark	O
affecting	VBG	advcl	O
transcript	NN	compound	O
stability	NN	dobj	O
.	.	punct	O

To	TO	mark	O
identify	VB	advcl	O
a	DT	det	O
suitable	JJ	amod	O
donor	NN	compound	B-Cell
cell	NN	compound	I-Cell
population	NN	dobj	I-Cell
for	IN	case	O
gene	NN	compound	O
therapy	NN	compound	O
applications	NNS	nmod	O
to	TO	case	O
the	DT	det	O
central	JJ	amod	B-Anatomical_system
nervous	JJ	amod	I-Anatomical_system
system	NN	nmod	I-Anatomical_system
,	,	punct	O
primary	JJ	amod	O
fibroblasts	NNS	nsubjpass	B-Cell
isolated	VBN	acl	O
from	IN	case	O
skin	NN	compound	B-Multi-tissue_structure
biopsies	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
maintained	VBN	conj	O
in	IN	case	O
culture	NN	nmod	B-Cell
are	VBP	auxpass	O
employed	VBN	ROOT	O
as	IN	case	O
autologous	JJ	amod	O
cells	NNS	nmod	B-Cell
for	IN	case	O
intracerebral	JJ	amod	B-Immaterial_anatomical_entity
grafting	VBG	nmod	O
within	IN	case	O
the	DT	det	O
adult	JJ	amod	O
rat	NN	compound	B-Organism
striatum	NN	nmod	B-Multi-tissue_structure
.	.	punct	O

No	DT	neg	O
significant	JJ	amod	O
differences	NNS	nsubjpass	O
between	IN	case	O
the	DT	det	O
two	CD	nummod	O
groups	NNS	nmod	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
tumor	NN	compound	B-Cancer
size	NN	nmod	O
,	,	punct	O
gender	NN	conj	O
,	,	punct	O
age	NN	conj	O
,	,	punct	O
histology	NN	conj	O
,	,	punct	O
differentiation	NN	conj	O
or	CC	cc	O
preoperative	JJ	amod	O
therapy	NN	conj	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
U	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
995	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
30	CD	nummod	O
micrograms	NNS	compound	O
/	:	punct	O
ml	NN	nsubj	O
)	-RRB-	punct	O
markedly	RB	advmod	O
prevented	VBD	ROOT	O
collagenase	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
collagenolysis	NN	dobj	O
.	.	punct	O

Using	VBG	advcl	O
human	JJ	amod	B-Organism
neuroblastoma	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	dobj	I-Cell
,	,	punct	O
SK	NN	compound	B-Cell
-	HYPH	punct	I-Cell
N	NNP	compound	I-Cell
-	HYPH	punct	I-Cell
MC	NNP	appos	I-Cell
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
treatment	NN	nsubj	O
of	IN	case	O
these	DT	det	O
cells	NNS	nmod	B-Cell
with	IN	case	O
FGF	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
resulted	VBD	ccomp	O
in	IN	case	O
early	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
both	DT	cc:preconj	O
Id	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
mRNA	NN	nmod	O
and	CC	cc	O
protein	NN	conj	O
.	.	punct	O

Studies	NNS	nsubjpass	O
were	VBD	auxpass	O
therefore	RB	advmod	O
performed	VBN	ROOT	O
with	IN	case	O
PECAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
null	JJ	amod	O
mice	NNS	nmod	O
to	TO	mark	O
further	RB	advmod	O
define	VB	xcomp	O
the	DT	det	O
involvement	NN	dobj	O
of	IN	case	O
PECAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
in	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
formation	NN	nmod	O
.	.	punct	O

These	DT	det	O
alterations	NNS	nsubj	O
of	IN	case	O
Bcl	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
family	NN	compound	O
proteins	NNS	nmod	O
were	VBD	cop	O
critical	JJ	ROOT	O
for	IN	case	O
apoptosis	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
the	DT	det	O
combination	NN	nmod	O
in	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Injection	NN	nsubj	O
of	IN	case	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	O
neutralizing	VBG	amod	O
antibodies	NNS	nmod	O
over	IN	case	O
a	DT	det	O
2	CD	nummod	O
-	HYPH	punct	O
week	NN	compound	O
period	NN	nmod	O
completely	RB	advmod	O
blocked	VBD	ROOT	O
alinidine	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
stimulated	VBN	amod	O
angiogenesis	NN	dobj	O
.	.	punct	O

Instead	RB	advmod	O
of	IN	case	O
cancer	NN	compound	B-Cancer
initiation	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
therefore	RB	advmod	O
likely	JJ	ROOT	O
that	IN	mark	O
Tsg101	NN	nsubj	B-Gene_or_gene_product
plays	VBZ	ccomp	O
a	DT	det	O
more	RBR	advmod	O
predominant	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	mark	O
spontaneously	RB	advmod	O
arising	VBG	acl	O
breast	NN	compound	B-Cancer
cancers	NNS	dobj	I-Cancer
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
metabolically	RB	advmod	O
-	HYPH	punct	O
altered	JJ	amod	O
islet	NN	compound	B-Tissue
endothelium	NN	nsubj	I-Tissue
might	MD	aux	O
affect	VB	ROOT	O
the	DT	det	O
beta	NN	compound	B-Cell
-	HYPH	punct	I-Cell
cell	NN	compound	I-Cell
microenvironment	NN	dobj	O
and	CC	cc	O
contribute	VBP	conj	O
to	TO	case	O
progressive	JJ	amod	O
type	NN	compound	O
2	CD	nummod	O
diabetic	JJ	amod	O
beta	NN	compound	B-Cell
-	:	punct	I-Cell
cell	NN	compound	I-Cell
dysfunction	NN	nmod	O
in	IN	case	O
GK	NN	compound	B-Organism
rats	NNS	nmod	I-Organism
.	.	punct	O

The	DT	det	O
semaphorin	NN	compound	B-Gene_or_gene_product
7A	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	O
Plexin	NN	compound	B-Gene_or_gene_product
C1	NN	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
lost	VBN	ROOT	O
during	IN	case	O
melanoma	NN	compound	B-Cancer
metastasis	NN	nmod	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Inhibition	NN	nsubj	O
of	IN	case	O
angiogenesis	NN	nmod	O
reverses	VBZ	appos	O
rodent	JJ	amod	O
obesity	NN	dobj	O
.	.	punct	O

VTAs	NNS	nsubj	B-Simple_chemical
inhibit	VBP	ROOT	O
specific	JJ	amod	O
factors	NNS	dobj	O
required	VBN	acl	O
to	TO	mark	O
induce	VB	xcomp	O
and	CC	cc	O
direct	VB	conj	O
the	DT	det	O
angiogenic	JJ	amod	O
process	NN	dobj	O
,	,	punct	O
with	IN	case	O
major	JJ	amod	O
activity	NN	nmod	O
against	IN	case	O
small	JJ	amod	O
tumor	NN	compound	B-Cancer
masses	NNS	nmod	I-Cancer
and	CC	cc	O
at	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Tissue
periphery	NN	conj	I-Tissue
,	,	punct	O
encompassing	VBG	advcl	O
monoclonal	JJ	amod	O
antibodies	NNS	dobj	O
and	CC	cc	O
small	JJ	amod	O
molecules	NNS	compound	O
inhibitors	NNS	conj	O
of	IN	case	O
the	DT	det	O
tyrosine	NN	compound	O
kinase	NN	compound	O
domain	NN	nmod	O
of	IN	case	O
the	DT	det	O
VEGF	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Many	JJ	amod	O
observations	NNS	nsubj	O
in	IN	case	O
various	JJ	amod	O
animal	NN	compound	O
models	NNS	nmod	O
and	CC	cc	O
humans	NNS	conj	B-Organism
support	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
remodeling	NN	nsubj	O
of	IN	prep	O
preexisting	VBG	pcomp	O
collateral	JJ	amod	B-Multi-tissue_structure
vessels	NNS	dobj	I-Multi-tissue_structure
is	VBZ	cop	O
the	DT	det	O
mechanism	NN	ccomp	O
of	IN	case	O
collateral	JJ	amod	B-Multi-tissue_structure
artery	NN	compound	I-Multi-tissue_structure
formation	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
mutation	NN	nsubj	O
of	IN	case	O
beclin	NN	nmod	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
or	CC	cc	O
other	JJ	amod	O
autophagy	NN	compound	O
genes	NNS	conj	O
may	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
cancers	NNS	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
increased	VBN	amod	O
rate	NN	nsubj	O
of	IN	case	O
glucose	NN	compound	B-Simple_chemical
transport	NN	nmod	O
is	VBZ	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
pp60src	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
the	DT	det	O
transforming	VBG	amod	O
protein	NN	appos	O
of	IN	case	O
Rous	JJ	amod	B-Organism
sarcoma	NN	compound	I-Organism
virus	NN	nmod	I-Organism
.	.	punct	O

Selective	JJ	amod	O
inhibition	NN	nsubj	O
of	IN	case	O
PI3K	NN	nmod	B-Gene_or_gene_product
/	:	punct	O
Akt	NNP	nsubj	B-Gene_or_gene_product
suppressed	VBD	ROOT	O
the	DT	det	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	O
induced	VBN	amod	O
BMP	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
promoter	NN	compound	O
activity	NN	dobj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
MnSO4	NN	compound	B-Simple_chemical
co	NN	compound	O
-	:	punct	O
operates	VBZ	ccomp	O
with	IN	case	O
overexpressed	VBN	amod	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	nmod	I-Gene_or_gene_product
in	IN	prep	O
inducing	VBG	pcomp	O
transformation	NN	dobj	O
,	,	punct	O
while	IN	mark	O
5	CD	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
azacytidine	NN	compound	I-Simple_chemical
transformation	NN	nsubj	O
is	VBZ	cop	O
independent	JJ	advcl	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	compound	I-Gene_or_gene_product
overexpression	NN	nmod	O
and	CC	cc	O
may	MD	aux	O
involve	VB	conj	O
alterations	NNS	dobj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

By	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
ras	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
tumors	NNS	nsubj	B-Cancer
were	VBD	cop	O
poorly	RB	advmod	O
differentiated	VBN	amod	O
fibrosarcomas	NNS	ROOT	B-Cancer
.	.	punct	O

A	DT	det	O
novel	JJ	amod	O
integrin	NN	compound	B-Gene_or_gene_product
alpha5beta1	NN	compound	I-Gene_or_gene_product
antagonistic	JJ	amod	O
peptide	NN	ROOT	O
,	,	punct	O
A5	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	appos	I-Gene_or_gene_product
,	,	punct	O
screened	VBN	acl	O
by	IN	case	O
Protein	NN	compound	O
Chip	NN	compound	O
system	NN	nmod	O
as	IN	case	O
a	DT	det	O
potent	JJ	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	nmod	O
.	.	punct	O

Elevated	JJ	amod	O
levels	NNS	ROOT	O
of	IN	case	O
diacylglycerol	NN	nmod	B-Simple_chemical
and	CC	cc	O
decreased	VBD	conj	O
phorbol	NN	compound	B-Simple_chemical
ester	NN	compound	I-Simple_chemical
sensitivity	NN	dobj	O
in	IN	case	O
ras	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
fibroblasts	NNS	nmod	B-Cell
.	.	punct	O

While	IN	mark	O
betulin	NN	nsubj	B-Simple_chemical
exhibited	VBD	advcl	O
only	RB	advmod	O
moderate	JJ	amod	O
anticancer	NN	compound	B-Cancer
activity	NN	dobj	O
in	IN	case	O
other	JJ	amod	O
human	JJ	amod	B-Organism
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
such	JJ	case	O
as	IN	mwe	O
hepatoma	NN	compound	B-Cell
SK	NN	compound	I-Cell
-	HYPH	punct	I-Cell
HEP	NNP	compound	I-Cell
-	HYPH	punct	I-Cell
1	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
prostate	NN	compound	B-Cell
carcinoma	NN	appos	I-Cell
PC	NN	compound	I-Cell
-	:	punct	I-Cell
3	CD	conj	I-Cell
,	,	punct	O
and	CC	cc	O
lung	NN	compound	B-Cell
carcinoma	NN	compound	I-Cell
NCI	NN	compound	I-Cell
-	:	punct	I-Cell
H460	NN	conj	I-Cell
,	,	punct	O
with	IN	case	O
IC	NN	compound	O
(	-LRB-	punct	O
50	CD	dep	O
)	-RRB-	punct	O
values	NNS	nmod	O
ranging	VBG	acl	O
from	IN	case	O
20	CD	compound	O
to	TO	dep	O
60	CD	nummod	O
microg	NN	compound	O
/	:	punct	O
mL	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
showed	VBD	ROOT	O
minor	JJ	amod	O
growth	NN	compound	O
inhibition	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
erythroleukemia	NN	compound	B-Cell
K562	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
IC	NN	dep	O
(	-LRB-	punct	O
50	CD	dep	O
)	-RRB-	punct	O
>	NN	dep	O
100	CD	nummod	O
microg	NN	dep	O
/	:	punct	O
mL	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
quantified	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
SMA	NN	nmod	I-Gene_or_gene_product
as	IN	case	O
a	DT	det	O
marker	NN	nmod	O
of	IN	case	O
myofibroblasts	NNS	nmod	B-Cell
in	IN	case	O
the	DT	det	O
invasive	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Histological	JJ	amod	O
examination	NN	nsubj	O
revealed	VBD	ROOT	O
cystic	JJ	amod	O
or	CC	cc	O
angiomatoid	NN	conj	O
spaces	NNS	dobj	O
of	IN	case	O
various	JJ	amod	O
sizes	NNS	nmod	O
lined	VBN	acl	O
by	IN	case	O
cuboidal	JJ	nmod	O
,	,	punct	O
low	JJ	amod	O
-	HYPH	punct	O
columnar	NN	conj	O
,	,	punct	O
or	CC	cc	O
flattened	VBN	amod	O
epithelioid	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
with	IN	case	O
vacuolated	VBN	amod	B-Organism_substance
cytoplasm	NN	nmod	I-Organism_substance
and	CC	cc	O
round	RB	conj	O
to	TO	case	O
oval	JJ	compound	O
nuclei	NNS	nmod	B-Cellular_component
.	.	punct	O

We	PRP	nsubj	O
did	VBD	ROOT	O
a	DT	det	O
blind	JJ	amod	O
prospective	JJ	amod	O
study	NN	dobj	O
in	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
to	TO	mark	O
assess	VB	xcomp	O
the	DT	det	O
significance	NN	dobj	O
of	IN	case	O
isolated	VBN	amod	B-Cell
tumor	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
ITC	NN	appos	B-Cell
)	-RRB-	punct	O
and	CC	cc	O
to	TO	mark	O
test	VB	conj	O
the	DT	det	O
hypothesis	NN	dobj	O
that	IN	mark	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	nsubjpass	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGFR	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	auxpass	O
expressed	VBN	ccomp	O
within	IN	case	O
the	DT	det	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	nmod	I-Multi-tissue_structure
at	IN	case	O
tumor	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
specific	JJ	amod	O
,	,	punct	O
premetastatic	JJ	amod	B-Multi-tissue_structure
sites	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

We	PRP	nsubj	O
conducted	VBD	ROOT	O
a	DT	det	O
retrospective	JJ	amod	O
medical	JJ	amod	O
record	NN	compound	O
review	NN	dobj	O
of	IN	case	O
patients	NNS	nmod	B-Organism
treated	VBN	acl	O
with	IN	case	O
rofecoxib	NN	nmod	B-Simple_chemical
for	IN	case	O
acute	JJ	amod	O
haemarthrosis	NN	nmod	O
,	,	punct	O
chronic	JJ	amod	O
synovitis	NN	conj	O
,	,	punct	O
target	NN	compound	O
joint	JJ	dobj	B-Multi-tissue_structure
or	CC	cc	O
pain	NN	conj	O
.	.	punct	O

The	DT	det	O
parameters	NNS	nsubj	O
considered	VBN	acl	O
are	VBP	ROOT	O
the	DT	det	O
number	NN	attr	O
of	IN	prep	O
platelets	NNS	pobj	B-Cell
and	CC	cc	O
their	PRP$	poss	O
aggregability	NN	conj	O
,	,	punct	O
prothrombin	NN	appos	B-Gene_or_gene_product
and	CC	cc	O
partial	JJ	amod	O
thromboplastin	NN	conj	B-Gene_or_gene_product
times	NNS	conj	O
,	,	punct	O
plasma	NN	compound	B-Organism_substance
fibrinogen	NN	compound	B-Gene_or_gene_product
concentration	NN	conj	O
and	CC	cc	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
procoagulant	JJ	amod	O
activity	NN	conj	O
.	.	punct	O

No	DT	neg	O
harmful	JJ	amod	O
side	JJ	amod	O
effects	NNS	nsubjpass	O
were	VBD	auxpass	O
attributed	VBN	ROOT	O
to	TO	case	O
TEMF	NN	nmod	O
.	.	punct	O

The	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
PDFs	NNS	nmod	O
with	IN	case	O
different	JJ	amod	O
amounts	NNS	nmod	O
of	IN	case	O
GDPs	NNS	nmod	B-Simple_chemical
were	VBD	auxpass	O
compared	VBN	ROOT	O
on	IN	case	O
morphological	JJ	amod	O
changes	NNS	nmod	O
in	IN	case	O
the	DT	det	O
peritoneal	JJ	amod	B-Multi-tissue_structure
membrane	NN	nmod	I-Multi-tissue_structure
in	IN	case	O
a	DT	det	O
RAGE	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	O
/	SYM	punct	O
-	HYPH	punct	O
mouse	NN	compound	O
model	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
when	WRB	advmod	O
the	DT	det	O
same	JJ	amod	O
cells	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
exposed	VBN	advcl	O
to	TO	case	O
step	NN	compound	O
-	HYPH	punct	O
wise	JJ	amod	O
increases	NNS	nmod	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
concentration	NN	nmod	O
in	IN	case	O
their	PRP$	nmod:poss	O
culture	NN	compound	O
medium	NN	nmod	O
,	,	punct	O
the	DT	det	O
development	NN	nsubjpass	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
resistance	NN	nmod	O
was	VBD	auxpass	O
accelerated	VBN	ROOT	O
.	.	punct	O

These	DT	nsubj	O
are	VBP	aux	O
exciting	VBG	ROOT	O
new	JJ	amod	O
functions	NNS	dobj	O
of	IN	prep	O
vitamins	NNS	pobj	B-Simple_chemical
that	IN	mark	O
nobody	NN	nsubj	O
could	MD	aux	O
have	VB	aux	O
predicted	VBN	relcl	O
only	RB	advmod	O
a	DT	quantmod	O
few	JJ	nummod	O
years	NNS	npadvmod	O
ago	RB	advmod	O
.	.	punct	O

These	DT	det	O
diagrams	NNS	nsubj	O
show	VBP	ROOT	O
the	DT	det	O
relative	JJ	amod	O
rates	NNS	dobj	O
of	IN	case	O
glycolysis	NN	nmod	O
,	,	punct	O
the	DT	det	O
tricarboxylic	JJ	amod	B-Simple_chemical
acid	NN	compound	I-Simple_chemical
cycle	NN	appos	O
,	,	punct	O
electron	NN	compound	B-Simple_chemical
transport	NN	conj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
malate	JJ	compound	B-Simple_chemical
-	HYPH	punct	O
aspartate	NN	compound	B-Simple_chemical
shuttle	NN	conj	O
in	IN	case	O
these	DT	det	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

Trib1	NN	nsubjpass	B-Gene_or_gene_product
and	CC	cc	O
Evi1	NN	conj	B-Gene_or_gene_product
were	VBD	cop	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	ROOT	O
due	JJ	case	O
to	TO	mwe	O
retroviral	JJ	amod	B-Organism
insertions	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
coexpression	NN	nsubj	O
of	IN	case	O
these	DT	det	O
genes	NNS	nmod	O
significantly	RB	advmod	O
accelerated	VBD	conj	O
the	DT	det	O
onset	NN	dobj	O
of	IN	case	O
Hoxa9	NN	compound	B-Gene_or_gene_product
/	:	punct	O
Meis1	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
induced	VBD	amod	O
AML	NN	nmod	B-Cancer
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
Trib1	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
Evi1	NN	conj	B-Gene_or_gene_product
are	VBP	cop	O
the	DT	det	O
key	JJ	amod	O
collaborators	NNS	ccomp	O
.	.	punct	O

The	DT	det	O
NBD	NN	compound	B-Simple_chemical
peptide	NN	nsubj	I-Simple_chemical
suppressed	VBD	ROOT	O
metastasis	NN	dobj	O
and	CC	cc	O
tongue	NN	conj	B-Cancer
tumor	NN	compound	I-Cancer
growth	NN	dobj	O
in	IN	case	O
GSAS	NN	nmod:npmod	B-Cell
/	:	punct	I-Cell
N5	NN	nmod:npmod	I-Cell
-	HYPH	punct	O
inoculated	VBN	amod	O
mice	NNS	nmod	B-Organism
,	,	punct	O
and	CC	cc	O
was	VBD	auxpass	O
accompanied	VBN	conj	O
by	IN	case	O
the	DT	det	O
downregulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
regulated	VBN	amod	O
metastasis	NN	compound	O
-	HYPH	punct	O
related	JJ	amod	O
molecules	NNS	nmod	O
in	IN	case	O
engrafted	VBN	amod	O
tongue	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Irreversible	JJ	amod	O
PHT	NN	nsubjpass	O
is	VBZ	auxpass	O
strongly	RB	advmod	O
associated	VBN	dep	O
with	IN	case	O
impaired	JJ	amod	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
apoptosis	NN	nmod	O
and	CC	cc	O
antiapoptotic	JJ	amod	O
signaling	NN	conj	O
from	IN	case	O
perivascular	JJ	amod	B-Cell
inflammatory	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

LeTx	NN	nsubj	B-Simple_chemical
also	RB	advmod	O
substantially	RB	advmod	O
inhibited	VBD	ROOT	O
the	DT	det	O
extracellular	JJ	amod	B-Immaterial_anatomical_entity
release	NN	dobj	O
of	IN	case	O
angioproliferative	JJ	amod	O
factors	NNS	nmod	O
including	VBG	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
interleukin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
8	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
basic	JJ	amod	B-Gene_or_gene_product
fibroblast	NN	compound	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
wide	JJ	amod	O
range	NN	nmod	O
of	IN	case	O
developmental	JJ	amod	O
and	CC	cc	O
physiological	JJ	conj	O
processes	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
serum	NN	compound	B-Organism_substance
calcium	NN	compound	B-Simple_chemical
regulation	NN	nmod	O
.	.	punct	O

Results	NNS	nsubjpass	O
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
with	IN	case	O
chi2	NN	compound	O
tests	NNS	nmod	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
compares	VBZ	ROOT	O
the	DT	det	O
radiomodification	NN	dobj	O
by	IN	case	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
DG	NNS	nmod	I-Simple_chemical
in	IN	case	O
monolayer	JJ	compound	B-Cell
cultures	NNS	nmod	I-Cell
and	CC	cc	O
spheroids	NNS	conj	B-Cell
of	IN	case	O
a	DT	det	O
human	JJ	amod	B-Organism
glioma	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
(	-LRB-	punct	O
BMG	NN	compound	B-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
)	-RRB-	punct	O
to	TO	mark	O
gain	VB	advcl	O
insight	NN	dobj	O
into	IN	case	O
the	DT	det	O
effects	NNS	nmod	O
in	IN	case	O
solid	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

3H	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Cytosine	NN	compound	I-Simple_chemical
arabinoside	NN	amod	I-Simple_chemical
incorporation	NN	nsubjpass	O
into	IN	case	O
the	DT	det	O
DNA	NN	nmod	B-Cellular_component
was	VBD	auxpass	O
enhanced	VBN	ROOT	O
1	CD	dobj	O
.	.	punct	O
33	CD	compound	O
-	HYPH	punct	O
to	TO	quantmod	O
18	CD	ROOT	O
.	.	punct	O
3	CD	nummod	O
-	HYPH	punct	O
fold	JJ	ROOT	O
over	RP	prep	O
respective	JJ	amod	O
controls	NNS	pobj	O
in	IN	case	O
14	CD	compound	O
of	IN	advmod	O
17	CD	nummod	O
patients	NNS	nmod	B-Organism
.	.	punct	O

Conversely	RB	advmod	O
,	,	punct	O
expression	NN	nsubj	O
of	IN	case	O
pAd	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
T34A	NN	nmod	I-Gene_or_gene_product
caused	VBD	ROOT	O
apoptosis	NN	dobj	O
in	IN	case	O
umbilical	JJ	amod	B-Cell
vein	NN	nmod	I-Cell
and	CC	cc	O
dermal	JJ	amod	B-Cell
microvascular	JJ	amod	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	conj	I-Cell
and	CC	cc	O
resulted	VBD	conj	O
in	IN	case	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
activity	NN	nmod	O
.	.	punct	O

As	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
ELISA	NN	nmod	O
and	CC	cc	O
immunoblot	NN	compound	O
assays	NNS	conj	O
,	,	punct	O
ras	NN	compound	B-Gene_or_gene_product
p21	NN	nsubj	I-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
serum	NN	nmod	B-Organism_substance
increased	VBD	ROOT	O
with	IN	case	O
increased	VBN	amod	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
biochemical	JJ	amod	O
mechanisms	NNS	nsubj	O
by	IN	case	O
which	WDT	nmod	O
MTSS1	NN	nsubj	B-Gene_or_gene_product
functions	VBZ	acl:relcl	O
in	IN	case	O
cells	NNS	nmod	B-Cell
and	CC	cc	O
the	DT	det	O
physiological	JJ	amod	O
role	NN	conj	O
of	IN	case	O
this	DT	det	O
protein	NN	nmod	O
in	IN	case	O
animals	NNS	nmod	O
remain	VBP	ROOT	O
largely	RB	advmod	O
unknown	JJ	xcomp	O
.	.	punct	O

Increased	VBN	amod	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
by	IN	case	O
malignant	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
has	VBZ	aux	O
been	VBN	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
high	JJ	amod	O
vascularity	NN	nmod	O
,	,	punct	O
increased	VBN	amod	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
growth	NN	conj	O
,	,	punct	O
and	CC	cc	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	conj	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
mice	NNS	nmod	B-Organism
bearing	VBG	acl	O
a	DT	det	O
small	JJ	amod	O
ear	NN	amod	B-Cancer
tumor	NN	dobj	I-Cancer
with	IN	case	O
a	DT	det	O
humanized	JJ	amod	O
antivascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
antibody	NN	nmod	I-Gene_or_gene_product
prevented	VBD	ROOT	O
the	DT	det	O
down	JJ	amod	O
-	HYPH	punct	O
regulation	NN	dobj	O
of	IN	case	O
leukocyte	NN	compound	B-Cell
-	HYPH	punct	O
vessel	NN	compound	B-Multi-tissue_structure
wall	NN	compound	I-Multi-tissue_structure
interactions	NNS	nmod	O
inside	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
nontreated	JJ	amod	O
group	NN	advcl	O
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
Osteopontin	NN	compound	B-Gene_or_gene_product
small	JJ	amod	O
interference	NN	compound	O
RNA	NN	nsubj	O
(	-LRB-	punct	O
siRNA	NN	appos	O
)	-RRB-	punct	O
inhibited	VBD	appos	O
osteopontin	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
and	CC	cc	O
cell	NN	compound	B-Cell
invasion	NN	conj	O
,	,	punct	O
promoted	VBD	ROOT	O
apoptosis	NN	dobj	O
in	IN	case	O
U251	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Folate	JJ	compound	B-Simple_chemical
supplementation	NN	nsubj	O
may	MD	aux	O
reduce	VB	ROOT	O
the	DT	det	O
risk	NN	dobj	O
of	IN	case	O
colorectal	JJ	amod	B-Pathological_formation
dysplasia	NN	nmod	I-Pathological_formation
and	CC	cc	O
cancer	NN	conj	B-Cancer
in	IN	case	O
subjects	NNS	nmod	O
with	IN	case	O
chronic	JJ	amod	O
ulcerative	JJ	amod	B-Pathological_formation
colitis	NN	nmod	I-Pathological_formation
(	-LRB-	punct	O
UC	NN	appos	B-Pathological_formation
)	-RRB-	punct	O
.	.	punct	O

Little	JJ	advmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
about	IN	case	O
the	DT	det	O
inhibitory	JJ	amod	O
mechanisms	NNS	nmod	O
.	.	punct	O

Simian	JJ	amod	B-Organism
virus	NN	compound	I-Organism
40	CD	nummod	I-Organism
large	JJ	amod	B-Gene_or_gene_product
T	NN	compound	I-Gene_or_gene_product
antigen	NN	nsubj	I-Gene_or_gene_product
and	CC	cc	O
two	CD	nummod	O
independent	JJ	amod	O
T	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
antigen	NN	compound	I-Gene_or_gene_product
segments	NNS	nsubj	O
sensitize	VBP	ROOT	O
cells	NNS	dobj	B-Cell
to	TO	case	O
apoptosis	NN	nmod	O
following	VBG	case	O
genotoxic	JJ	amod	O
damage	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Chang	NN	compound	B-Cell
hepatocytes	NNS	nsubj	I-Cell
grown	VBN	acl	O
in	IN	prep	O
the	DT	det	O
coculture	NN	pobj	O
conditioned	JJ	amod	O
media	NNS	npadvmod	O
have	VBP	appos	O
an	DT	det	O
increase	NN	dobj	O
in	IN	case	O
TNF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
Fas	NN	compound	B-Gene_or_gene_product
ligand	NN	conj	I-Gene_or_gene_product
.	.	punct	O

RNA	NN	compound	O
interference	NN	nsubj	O
targeting	VBG	acl	O
Met	VBN	dobj	B-Gene_or_gene_product
in	IN	case	O
these	DT	det	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
significant	JJ	amod	O
delay	NN	nmod	O
in	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
control	NN	compound	O
cells	NNS	nmod	B-Cell
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
confirm	VBP	ROOT	O
the	DT	det	O
importance	NN	dobj	O
of	IN	case	O
tissue	NN	compound	B-Tissue
architecture	NN	nmod	O
and	CC	cc	O
polarity	NN	conj	O
in	IN	case	O
malignant	JJ	amod	O
progression	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
isoforms	NNS	nsubjpass	O
and	CC	cc	O
its	PRP$	nmod:poss	O
receptors	NNS	nmod:poss	O
'	POS	case	O
mRNA	NN	conj	O
were	VBD	auxpass	O
expressed	VBN	dep	O
in	IN	case	O
neuroblastoma	NN	nmod	B-Cancer
and	CC	cc	O
control	NN	conj	O
tissues	NNS	dep	B-Tissue
.	.	punct	O

This	DT	nsubj	O
probably	RB	advmod	O
results	VBZ	ROOT	O
in	IN	case	O
the	DT	det	O
slower	JJR	amod	O
rate	NN	nmod	O
of	IN	case	O
osteogenesis	NN	nmod	O
seen	VBN	acl	O
at	IN	case	O
the	DT	det	O
1	CD	nummod	O
mm	NN	nmod	O
/	HYPH	punct	O
day	NN	compound	O
distraction	NN	compound	O
rate	NN	dep	O
compared	VBN	acl	O
with	IN	prep	O
the	DT	det	O
0	CD	pobj	O
.	.	punct	O
5	CD	nummod	O
mm	NN	ROOT	O
/	,	punct	O
day	NN	compound	O
distraction	NN	compound	O
rate	NN	appos	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
determined	VBD	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
U	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
995	CD	nmod	I-Gene_or_gene_product
to	TO	mark	O
inhibiting	VBG	acl	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
growth	NN	dobj	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
detected	VBD	ROOT	O
strong	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
AKT	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
allograft	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
specifically	RB	advmod	O
AKT2	NN	dobj	B-Gene_or_gene_product
as	IN	case	O
the	DT	det	O
predominant	JJ	amod	O
isoform	NN	nmod	O
involved	VBN	acl	O
.	.	punct	O

Using	VBG	advcl	O
tamoxifen	NN	compound	B-Simple_chemical
and	CC	cc	O
doxorubicin	NN	conj	B-Simple_chemical
-	HYPH	punct	O
sensitive	JJ	conj	O
and	CC	cc	O
-	HYPH	punct	O
resistant	JJ	conj	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	dobj	I-Cell
as	IN	case	O
models	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
doxorubicin	NN	compound	B-Simple_chemical
-	:	punct	O
but	CC	cc	O
not	RB	cc	O
tamoxifen	NN	compound	B-Simple_chemical
-	HYPH	punct	O
resistance	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
nuclear	JJ	amod	B-Cellular_component
accumulation	NN	nmod	O
of	IN	case	O
FOXO3a	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
consistent	JJ	advcl	O
with	IN	case	O
the	DT	det	O
finding	NN	nmod	O
that	IN	mark	O
sustained	JJ	amod	O
nuclear	JJ	amod	B-Cellular_component
FOXO3a	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
.	.	punct	O

Lysates	NNS	nsubjpass	B-Organism_substance
of	IN	case	O
cells	NNS	nmod	B-Cell
from	IN	case	O
the	DT	det	O
granulocyte	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
macrophage	NN	compound	I-Gene_or_gene_product
colony	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
stimulating	NN	compound	I-Gene_or_gene_product
factor	NN	intj	I-Gene_or_gene_product
(	-LRB-	punct	O
GM	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NNP	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
-	:	punct	O
dependent	JJ	amod	O
myeloid	JJ	amod	B-Cell
leukemic	JJ	amod	I-Cell
cell	NN	compound	I-Cell
line	NN	compound	I-Cell
TF1	NN	nmod	I-Cell
were	VBD	auxpass	O
separated	VBN	ROOT	O
into	IN	case	O
high	JJ	amod	O
molecular	JJ	amod	O
weight	NN	compound	O
(	-LRB-	punct	O
HMW	NN	appos	O
)	-RRB-	punct	O
pellets	NNS	nmod	O
of	IN	case	O
intact	JJ	amod	O
DNA	NN	nmod	B-Cellular_component
and	CC	cc	O
supernatants	NNS	conj	O
of	IN	case	O
fragmented	JJ	amod	O
low	JJ	amod	O
MW	NN	compound	O
(	-LRB-	punct	O
LMW	NN	compound	O
)	-RRB-	punct	O
DNA	NN	nmod	B-Cellular_component
,	,	punct	O
and	CC	cc	O
the	DT	det	O
DNA	NN	nsubjpass	B-Cellular_component
purified	VBN	acl	O
from	IN	case	O
these	DT	det	O
fractions	NNS	nmod	O
was	VBD	auxpass	O
quantified	VBN	conj	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
This	DT	det	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
designed	VBN	dep	O
to	TO	mark	O
reconcile	VB	xcomp	O
our	PRP$	nmod:poss	O
previous	JJ	amod	O
findings	NNS	dobj	O
with	IN	case	O
the	DT	det	O
recent	JJ	amod	O
report	NN	nmod	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
allelic	JJ	amod	O
deletion	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-Organism
colon	NN	compound	B-Cancer
cancers	NNS	nmod	I-Cancer
associated	VBN	acl	O
with	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
.	.	punct	O

Media	NNS	nsubj	O
supplemented	VBD	ROOT	O
with	IN	prep	O
and	CC	cc	O
without	IN	conj	O
10	CD	nummod	O
%	NN	compound	O
Oxygent	NNP	nsubjpass	B-Simple_chemical
were	VBD	auxpass	O
compared	VBN	conj	O
in	IN	prep	O
all	DT	det	O
assessments	NNS	pobj	O
.	.	punct	O

TEMF	NN	compound	O
treatment	NN	nsubj	O
continued	VBD	ROOT	O
for	IN	case	O
3	CD	nummod	O
additional	JJ	amod	O
weeks	NNS	nmod	O
.	.	punct	O

Neoplastic	JJ	amod	O
transformation	NN	nsubj	O
by	IN	case	O
Notch	NN	nmod	B-Gene_or_gene_product
requires	VBZ	ROOT	O
nuclear	JJ	amod	B-Cellular_component
localization	NN	dobj	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
REF	NN	nmod	B-Cell
or	CC	cc	O
REF	NN	conj	B-Cell
expressing	VBG	acl	O
full	JJ	amod	O
-	HYPH	punct	O
length	NN	compound	O
T	NN	compound	B-Gene_or_gene_product
antigen	NN	dobj	I-Gene_or_gene_product
,	,	punct	O
an	DT	det	O
N	NN	nmod:npmod	O
-	HYPH	punct	O
terminal	JJ	amod	O
segment	NN	appos	O
,	,	punct	O
or	CC	cc	O
T251	NN	compound	O
-	:	punct	O
708	CD	conj	O
resulted	VBD	ROOT	O
in	IN	case	O
increased	VBN	amod	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
responsive	JJ	amod	O
MDM2	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
;	:	punct	O
apoptosis	NN	nsubj	O
occurred	VBD	parataxis	O
through	IN	case	O
a	DT	det	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
pathway	NN	nmod	O
,	,	punct	O
as	IN	mark	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
null	NN	amod	O
cells	NNS	nsubj	O
expressing	VBG	acl	O
these	DT	det	O
T	NN	compound	B-Gene_or_gene_product
antigens	NNS	dobj	I-Gene_or_gene_product
were	VBD	cop	O
resistant	JJ	advcl	O
to	TO	case	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NNP	nmod:npmod	I-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
dependent	JJ	amod	O
apoptosis	NN	nmod	O
,	,	punct	O
transcriptional	JJ	amod	O
repression	NN	conj	O
,	,	punct	O
and	CC	cc	O
cell	NN	compound	B-Cell
transformation	NN	conj	O
by	IN	case	O
phosphorylation	NN	nmod	O
of	IN	case	O
the	DT	det	O
55	CD	nummod	O
-	HYPH	punct	O
kilodalton	NN	compound	O
E1B	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
adenovirus	NN	compound	I-Organism
type	NN	nmod	I-Organism
5	CD	nummod	I-Organism
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
OSCC	NN	compound	B-Cancer
samples	NNS	nsubj	I-Cancer
had	VBD	dep	O
an	DT	det	O
average	JJ	amod	O
h	NN	compound	O
-	HYPH	punct	O
MVD	NN	compound	O
score	NN	dobj	O
of	IN	case	O
27	CD	nmod	O
.	.	punct	O
7	CD	nummod	O
/	SYM	punct	O
mm	NN	ROOT	O
(	-LRB-	punct	O
2	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

Administration	NN	ROOT	O
of	IN	case	O
thalidomide	NN	nmod	B-Simple_chemical
at	IN	case	O
the	DT	det	O
concentration	NN	nmod	O
of	IN	case	O
0	CD	nmod	O
.	.	punct	O
01	CD	nummod	O
microM	NN	nsubj	O
increased	VBD	ROOT	O
cell	NN	compound	B-Cell
migration	NN	dobj	O
,	,	punct	O
while	IN	mark	O
at	IN	case	O
10	CD	nummod	O
microM	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
decreased	VBD	advcl	O
cell	NN	compound	B-Cell
migration	NN	dobj	O
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
Myofibroblasts	NNS	nsubj	B-Cell
represent	VBP	ROOT	O
an	DT	det	O
important	JJ	amod	O
prognostic	JJ	amod	O
factor	NN	dobj	O
for	IN	case	O
invasive	JJ	amod	O
growth	NN	nmod	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
translated	VBN	acl:relcl	O
into	IN	case	O
a	DT	det	O
poor	JJ	amod	O
clinical	JJ	amod	O
prognosis	NN	nmod	O
for	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
invasive	JJ	amod	B-Cancer
breast	NN	compound	I-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

TUNEL	NN	compound	O
assay	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
assess	VB	xcomp	O
apoptosis	NN	dobj	O
.	.	punct	O

Activated	VBN	amod	O
platelets	NNS	nsubj	B-Cell
enhance	VBP	ROOT	O
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
invasion	NN	dobj	O
in	IN	case	O
a	DT	det	O
cellular	JJ	amod	B-Cell
model	NN	nmod	O
of	IN	case	O
metastasis	NN	nmod	O
.	.	punct	O

The	DT	det	O
permeability	NN	nsubj	O
of	IN	case	O
plasma	NN	compound	B-Cellular_component
membranes	NNS	nmod	I-Cellular_component
for	IN	case	O
K	NN	nmod	B-Simple_chemical
+	CC	cc	I-Simple_chemical
increases	VBZ	ROOT	O
2	CD	dobj	O
.	.	punct	O
75	CD	nummod	O
fold	NN	ROOT	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
passive	JJ	amod	O
flux	NN	nsubj	O
of	IN	prep	O
Na	NN	pobj	B-Simple_chemical
+	CC	cc	I-Simple_chemical
diminishes	NNS	advcl	O
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
cytolytic	JJ	amod	O
effectors	NNS	compound	O
perforin	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
granzyme	NN	compound	B-Gene_or_gene_product
B9	NN	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
the	DT	det	O
granule	NN	compound	B-Cellular_component
membrane	NN	compound	I-Cellular_component
protein	NN	compound	O
TIA1	NN	conj	B-Gene_or_gene_product
were	VBD	auxpass	O
examined	VBN	ROOT	O
in	IN	case	O
24	CD	nummod	O
putative	JJ	amod	O
NK	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
lymphomas	NNS	nmod	I-Cancer
,	,	punct	O
18	CD	nummod	O
postthymic	JJ	amod	O
T	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
lymphomas	NNS	appos	I-Cancer
(	-LRB-	punct	O
one	CD	nummod	O
case	NN	compound	O
CD8	NN	dep	B-Gene_or_gene_product
+	CC	cc	O
CD56	NN	conj	B-Gene_or_gene_product
+	CC	cc	O
and	CC	cc	O
three	CD	nummod	O
anaplastic	JJ	amod	B-Cancer
large	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
lymphomas	NNS	conj	I-Cancer
(	-LRB-	punct	O
ALCL	NN	appos	B-Cancer
)	-RRB-	punct	O
,	,	punct	O
three	CD	nummod	O
T	NN	nmod:npmod	B-Cancer
-	HYPH	punct	I-Cancer
lymphoblastic	JJ	amod	I-Cancer
lymphomas	NNS	conj	I-Cancer
,	,	punct	O
and	CC	cc	O
20	CD	nummod	O
B	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
lymphomas	NNS	conj	I-Cancer
.	.	punct	O

Their	PRP$	poss	O
resistance	NN	nsubjpass	O
to	IN	case	O
the	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
invasive	JJ	amod	O
action	NN	nmod	O
of	IN	case	O
TGFbeta	NN	nmod	B-Gene_or_gene_product
was	VBD	auxpass	O
explained	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
failure	NN	nmod	O
of	IN	case	O
TGFbeta	NN	nmod	B-Gene_or_gene_product
to	TO	mark	O
upregulate	VB	acl	O
TIMPs	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
PAI	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
I	NNP	conj	I-Gene_or_gene_product
,	,	punct	O
in	IN	case	O
contrast	NN	nmod	O
to	TO	case	O
the	DT	det	O
TGFbeta	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
upregulation	NN	nmod	O
noted	VBN	acl	O
in	IN	case	O
parental	JJ	amod	O
HTR8	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

35	CD	nummod	O
%	NN	nsubj	O
of	IN	prep	O
eyes	NNS	pobj	B-Organ
improved	VBD	ccomp	O
their	PRP$	nmod:poss	O
BCVA	NN	dobj	O
by	IN	case	O
2	CD	nummod	O
lines	NNS	nmod	O
or	CC	cc	O
more	JJR	conj	O
,	,	punct	O
45	CD	nummod	O
%	NN	nsubj	O
remained	VBD	ROOT	O
stable	JJ	acomp	O
and	CC	cc	O
18	CD	nummod	O
%	NN	nsubj	O
lost	VBD	conj	O
2	CD	nummod	O
lines	NNS	dobj	O
or	CC	cc	O
more	JJR	conj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
curcumin	NN	compound	B-Simple_chemical
dose	NN	nsubj	O
-	:	punct	O
dependently	RB	advmod	O
inhibited	VBN	ccomp	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	nummod	O
)	-RRB-	punct	O
the	DT	det	O
proliferation	NN	dep	O
of	IN	case	O
MCF	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
7	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
treatment	NN	compound	O
possibilities	VBZ	nsubjpass	O
for	IN	case	O
ischemia	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
disease	NN	nmod	O
are	VBP	auxpass	O
limited	JJ	ROOT	O
.	.	punct	O

Downstream	JJ	amod	O
targets	NNS	nsubj	O
of	IN	case	O
Plexin	NN	compound	B-Gene_or_gene_product
C1	NN	compound	I-Gene_or_gene_product
signaling	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-Organism
melanocytes	NNS	nmod	B-Cell
include	VBP	ROOT	O
cofilin	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
LIM	NN	compound	B-Gene_or_gene_product
kinase	NN	conj	I-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
both	DT	nsubj	O
of	IN	case	O
which	WDT	nmod	O
are	VBP	cop	O
critical	JJ	amod	O
mediators	NNS	ccomp	O
of	IN	case	O
cell	NN	compound	B-Cell
adhesion	NN	nmod	O
and	CC	cc	O
migration	NN	conj	O
.	.	punct	O

Antiangiogenesis	NN	compound	O
therapy	NN	nsubj	O
might	MD	aux	O
have	VB	ROOT	O
a	DT	det	O
role	NN	dobj	O
in	IN	mark	O
reducing	VBG	advcl	O
regional	JJ	amod	O
metastasis	NN	dobj	O
.	.	punct	O

Through	IN	case	O
this	DT	det	O
domain	NN	nmod	O
,	,	punct	O
Evi	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nsubj	I-Gene_or_gene_product
physically	RB	advmod	O
interacts	VBZ	ROOT	O
with	IN	case	O
Smad3	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
an	DT	det	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
mediator	NN	appos	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
signaling	NN	nmod	O
,	,	punct	O
thereby	RB	advmod	O
suppressing	VBG	advcl	O
the	DT	det	O
transcriptional	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
Smad3	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

LRP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nsubjpass	I-Gene_or_gene_product
also	RB	advmod	O
is	VBZ	auxpass	O
implicated	VBN	ROOT	O
in	IN	case	O
integrin	NN	compound	B-Gene_or_gene_product
maturation	NN	nmod	O
.	.	punct	O

The	DT	det	O
percentage	NN	nsubj	O
of	IN	case	O
cell	NN	compound	B-Cell
apoptosis	NN	nmod	O
increased	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
enhancing	NN	nmod	O
of	IN	case	O
concentration	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	dobj	O
both	CC	det	O
substitution	NN	dep	O
of	IN	case	O
glucose	NN	nmod	B-Simple_chemical
for	IN	case	O
pyruvate	NN	nmod	B-Simple_chemical
and	CC	cc	O
treatment	NN	conj	O
with	IN	case	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
deoxyglucose	NN	amod	I-Simple_chemical
enhanced	VBN	amod	O
apoptosis	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
tumor	NN	compound	B-Gene_or_gene_product
necrosis	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
TNF	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
CD95	NN	compound	B-Gene_or_gene_product
agonistic	JJ	amod	O
antibody	NN	conj	O
,	,	punct	O
and	CC	cc	O
TNF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
related	JJ	amod	I-Gene_or_gene_product
apoptosis	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducing	VBG	amod	I-Gene_or_gene_product
ligand	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
TRAIL	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

Thalidomide	NN	compound	B-Simple_chemical
[	-LRB-	punct	O
alpha	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
N	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
phthalimido	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
glutarimide	NN	nsubjpass	I-Simple_chemical
]	-RRB-	punct	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
potent	JJ	amod	O
inhibitor	NN	xcomp	O
of	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
mechanism	NN	nsubj	O
of	IN	case	O
its	PRP$	nmod:poss	O
inhibitory	JJ	amod	O
action	NN	nmod	O
remains	VBZ	conj	O
unclear	JJ	xcomp	O
.	.	punct	O

As	IN	case	O
such	JJ	amod	O
,	,	punct	O
sustained	JJ	amod	O
nuclear	JJ	amod	B-Cellular_component
FOXO3a	NN	compound	B-Gene_or_gene_product
expression	NN	nsubj	O
in	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
may	MD	aux	O
culminate	VB	ROOT	O
in	IN	case	O
cancer	NN	compound	B-Cancer
progression	NN	nmod	O
and	CC	cc	O
the	DT	det	O
development	NN	conj	O
of	IN	case	O
an	DT	det	O
aggressive	JJ	amod	O
phenotype	NN	nmod	O
similar	JJ	amod	O
to	TO	case	O
that	DT	nmod	O
observed	VBN	acl	O
in	IN	case	O
cytotoxic	JJ	amod	O
chemotherapy	NN	compound	O
resistant	JJ	amod	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
models	NNS	nmod	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Mesenchymal	JJ	amod	B-Cell
stem	NN	compound	I-Cell
cells	NNS	compound	I-Cell
(	-LRB-	punct	O
MSCs	NNS	appos	B-Cell
)	-RRB-	punct	O
transplantation	NN	nsubj	O
is	VBZ	cop	O
of	IN	case	O
therapeutic	JJ	amod	O
potential	NN	appos	O
after	IN	case	O
ischemic	JJ	amod	O
injury	NN	nmod	O
in	IN	case	O
both	CC	cc:preconj	O
experimental	JJ	amod	O
and	CC	cc	O
clinical	JJ	conj	O
studies	NNS	nmod	O
.	.	punct	O

Choroidal	JJ	amod	B-Multi-tissue_structure
hyperpermeability	NN	nsubjpass	O
was	VBD	auxpass	O
reduced	VBN	ROOT	O
in	IN	case	O
every	DT	det	O
case	NN	nmod	O
.	.	punct	O

In	IN	case	O
only	RB	advmod	O
3	CD	nummod	O
out	IN	advmod	O
of	IN	advmod	O
13	CD	nummod	O
cases	NNS	nmod	O
,	,	punct	O
representing	VBG	acl	O
patients	NNS	dobj	B-Organism
with	IN	case	O
adenocarcinomas	NNS	nmod	B-Cancer
of	IN	case	O
the	DT	det	O
stomach	NN	compound	B-Organ
receiving	VBG	compound	O
chemotherapy	NN	nmod	O
,	,	punct	O
was	VBD	cop	O
ras	NN	compound	B-Gene_or_gene_product
p21	NN	nsubjpass	I-Gene_or_gene_product
detected	VBN	acl	O
at	IN	case	O
elevated	JJ	amod	O
levels	NNS	nmod	O
,	,	punct	O
whereas	IN	dep	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
the	DT	det	O
following	VBG	amod	O
types	NNS	nmod	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
no	DT	neg	O
substantial	JJ	amod	O
change	NN	nsubjpass	O
in	IN	case	O
serum	NN	compound	B-Organism_substance
ras	NN	compound	B-Gene_or_gene_product
p21	NN	nmod	I-Gene_or_gene_product
was	VBD	auxpass	O
observed	VBN	ROOT	O
;	:	punct	O
nine	CD	dep	O
with	IN	case	O
breast	NN	nmod	B-Cancer
,	,	punct	O
5	CD	nummod	O
colon	NN	conj	B-Cancer
,	,	punct	O
5	CD	nummod	O
lung	NN	conj	B-Cancer
,	,	punct	O
5	CD	nummod	O
ovarian	JJ	appos	B-Cancer
and	CC	cc	O
5	CD	conj	O
hepatocellular	JJ	amod	B-Cancer
carcinomas	NNS	conj	I-Cancer
.	.	punct	O

In	IN	case	O
seven	CD	nummod	O
diabetic	JJ	amod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
proliferative	JJ	amod	O
retinopathy	NN	nmod	O
,	,	punct	O
the	DT	det	O
most	RBS	advmod	O
profound	JJ	amod	O
finding	NN	nsubj	O
was	VBD	cop	O
a	DT	det	O
significant	JJ	amod	O
decrease	NN	ROOT	O
of	IN	case	O
the	DT	det	O
PEDF	NN	compound	B-Gene_or_gene_product
level	NN	nmod	O
(	-LRB-	punct	O
mean	NN	amod	O
value	NN	dep	O
:	:	punct	O
237	CD	nummod	O
ng	NN	compound	O
/	:	punct	O
ml	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
whereas	IN	dep	O
VEGF	NN	compound	B-Gene_or_gene_product
levels	NNS	nsubj	O
were	VBD	cop	O
comparable	JJ	parataxis	O
to	TO	case	O
diabetic	JJ	amod	O
patients	NNS	nmod	B-Organism
without	IN	case	O
proliferation	NN	nmod	O
(	-LRB-	punct	O
mean	NN	amod	O
value	NN	nmod	O
:	:	punct	O
3153	CD	dep	O
;	:	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
003	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

Upregulation	NN	nsubjpass	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptors	NNS	nmod	I-Gene_or_gene_product
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
advanced	JJ	amod	O
neuroblastoma	NN	nmod	B-Cancer
.	.	punct	O

Hematogenous	JJ	amod	O
metastasis	NN	nsubj	O
in	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
requires	VBZ	ROOT	O
isolated	VBN	amod	B-Cell
tumor	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
and	CC	cc	O
expression	NN	conj	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Characterization	NN	ROOT	O
of	IN	case	O
the	DT	det	O
metabolic	JJ	amod	O
changes	NNS	nmod	O
underlying	VBG	acl	O
growth	NN	compound	O
factor	NN	compound	O
angiogenic	JJ	amod	O
activation	NN	dobj	O
:	:	punct	O
identification	NN	dep	O
of	IN	case	O
new	JJ	amod	O
potential	JJ	amod	O
therapeutic	JJ	amod	O
targets	NNS	nmod	O
.	.	punct	O

The	DT	det	O
interaction	NN	nsubj	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
its	PRP$	nmod:poss	O
receptors	NNS	conj	O
at	IN	case	O
gene	NN	compound	O
and	CC	cc	O
protein	NN	conj	O
levels	NNS	nmod	O
in	IN	case	O
neuroblastoma	NN	nmod	B-Cancer
remains	VBZ	ROOT	O
widely	RB	advmod	O
unknown	JJ	xcomp	O
.	.	punct	O

Vinculin	NN	compound	B-Gene_or_gene_product
staining	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
leading	JJ	amod	O
edge	NN	nsubj	O
of	IN	case	O
ECs	NNS	nmod	B-Cell
on	IN	prep	O
15	CD	nummod	O
-	HYPH	punct	O
microm	JJ	amod	O
wide	JJ	amod	O
strips	NNS	pobj	O
had	VBD	ccomp	O
focal	JJ	amod	O
adhesions	NNS	dobj	O
that	WDT	nsubjpass	O
were	VBD	auxpass	O
oriented	VBN	acl:relcl	O
with	IN	case	O
their	PRP$	nmod:poss	O
lamellipodial	JJ	amod	O
protrusion	NN	nmod	O
and	CC	cc	O
the	DT	det	O
direction	NN	conj	O
of	IN	case	O
cell	NN	compound	B-Cell
migration	NN	nmod	O
;	:	punct	O
this	DT	det	O
arrangement	NN	nsubj	O
of	IN	case	O
the	DT	det	O
focal	JJ	amod	O
adhesions	NNS	nmod	O
may	MD	aux	O
promote	VB	parataxis	O
EC	NN	compound	B-Cell
migration	NN	dobj	O
.	.	punct	O

PATIENTS	NNS	ROOT	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
The	DT	det	O
paraffin	NN	amod	B-Cancer
sections	NNS	nsubjpass	I-Cancer
from	IN	case	O
49	CD	nummod	O
subjects	NNS	nmod	B-Organism
with	IN	case	O
OSCC	NN	nmod	B-Cancer
were	VBD	auxpass	O
subjected	VBN	dep	O
to	TO	case	O
immunohistochemical	JJ	amod	O
studies	NNS	nmod	O
to	TO	mark	O
measure	VB	xcomp	O
the	DT	det	O
highest	JJS	amod	O
MVD	NN	dobj	O
(	-LRB-	punct	O
h	NN	compound	O
-	HYPH	punct	O
MVD	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
cytoplasmic	JJ	amod	B-Organism_substance
immunoreactivity	NN	conj	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
mean	NN	amod	O
sVAP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
level	NN	nsubj	O
for	IN	case	O
cancer	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
was	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	dep	O
relative	JJ	case	O
to	TO	case	O
controls	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
decreased	VBD	conj	O
with	IN	case	O
disease	NN	compound	B-Cancer
progression	NN	nmod	O
.	.	punct	O

The	DT	det	O
authors	NNS	nsubj	O
studied	VBD	ROOT	O
insulin	NN	compound	B-Gene_or_gene_product
effects	NNS	dobj	O
on	IN	case	O
tumor	NN	nmod	B-Cancer
and	CC	cc	O
skeletal	JJ	amod	B-Tissue
muscle	NN	compound	I-Tissue
metabolism	NN	conj	O
with	IN	case	O
2	CD	nummod	B-Simple_chemical
-	SYM	punct	I-Simple_chemical
[	-LRB-	punct	I-Simple_chemical
18F	NN	nummod	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
fluoro	NNS	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
2	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
deoxy	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
D	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
glucose	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
[	-LRB-	punct	B-Simple_chemical
18F	NN	dep	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
FDG	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
positron	NN	compound	O
emission	NN	compound	O
tomography	NN	conj	O
(	-LRB-	punct	O
PET	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
two	CD	nummod	O
type	NN	nmod	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
tumor	NN	compound	I-Gene_or_gene_product
hexokinase	NN	compound	I-Gene_or_gene_product
RNA	NN	compound	O
transcripts	NNS	nmod	O
in	IN	case	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

Platelet	NN	compound	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
cell	NN	compound	I-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
molecule	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
PECAM	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
has	VBZ	aux	O
been	VBN	auxpass	O
previously	RB	advmod	O
implicated	VBN	ROOT	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
;	:	punct	O
additionally	RB	advmod	O
,	,	punct	O
anti	JJ	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
PECAM	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
antibodies	NNS	nsubjpass	I-Gene_or_gene_product
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	parataxis	O
to	TO	mark	O
inhibit	VB	xcomp	O
in	FW	amod	O
vivo	FW	dep	O
angiogenesis	NN	dobj	O
.	.	punct	O

Effect	NN	ROOT	O
of	IN	case	O
transplanted	VBN	amod	O
mesenchymal	JJ	amod	B-Cell
stem	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
from	IN	case	O
rats	NNS	nmod	B-Organism
of	IN	case	O
different	JJ	amod	O
ages	NNS	nmod	O
on	IN	case	O
the	DT	det	O
improvement	NN	nmod	O
of	IN	case	O
heart	NN	compound	B-Organ
function	NN	nmod	O
after	IN	case	O
acute	JJ	amod	O
myocardial	JJ	amod	B-Multi-tissue_structure
infarction	NN	nmod	O
.	.	punct	O

Peritoneal	JJ	amod	B-Multi-tissue_structure
NOS	NN	compound	B-Gene_or_gene_product
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
increased	VBN	ROOT	O
fivefold	RB	advmod	O
in	IN	case	O
long	JJ	amod	O
-	HYPH	punct	O
term	NN	compound	O
PD	NN	compound	O
patients	NNS	nmod	B-Organism
compared	VBN	case	O
with	IN	case	O
control	JJ	amod	O
subjects	NNS	advcl	O
.	.	punct	O

The	DT	det	O
aims	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
were	VBD	ROOT	O
to	TO	mark	O
compare	VB	xcomp	O
,	,	punct	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
the	DT	det	O
antiangiogenic	JJ	amod	O
and	CC	cc	O
antitumor	JJ	conj	B-Cancer
activities	NNS	intj	O
of	IN	case	O
metronomic	JJ	amod	O
irinotecan	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
CPT	NN	dep	B-Simple_chemical
-	:	punct	I-Simple_chemical
11	CD	nummod	I-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
oxaliplatin	NN	appos	B-Simple_chemical
(	-LRB-	punct	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
OHP	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
fluorouracil	NN	conj	I-Simple_chemical
(	-LRB-	punct	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
in	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
metronomic	JJ	amod	O
combination	NN	dobj	O
of	IN	case	O
these	DT	det	O
drugs	NNS	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
when	WRB	advmod	O
200	CD	nummod	O
micrograms	NNS	compound	O
U	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
995	CD	nsubjpass	I-Gene_or_gene_product
was	VBD	auxpass	O
injected	VBN	ROOT	O
i	LS	dobj	O
.	.	punct	O
p	NN	ROOT	O
.	.	punct	O
into	IN	case	O
mice	NNS	nmod	B-Organism
it	PRP	nsubj	O
suppressed	VBD	ROOT	O
sarcoma	NN	compound	B-Cell
-	:	punct	I-Cell
180	CD	nummod	I-Cell
cell	NN	compound	I-Cell
growth	NN	dobj	O
and	CC	cc	O
B16	NN	compound	B-Cell
-	:	punct	I-Cell
F10	NN	compound	I-Cell
mouse	NN	compound	I-Cell
melanoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
metastasis	NN	conj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
concluded	VBN	ROOT	O
that	IN	mark	O
there	EX	expl	O
is	VBZ	ccomp	O
no	DT	neg	O
major	JJ	amod	O
difference	NN	nsubj	O
between	IN	case	O
the	DT	det	O
PET	NN	compound	O
investigation	NN	nmod	O
of	IN	case	O
glucose	NN	compound	B-Simple_chemical
metabolism	NN	nmod	O
and	CC	cc	O
the	DT	det	O
less	RBR	amod	O
expensive	JJ	amod	O
SPET	NN	compound	O
measurement	NN	conj	O
of	IN	case	O
amino	NN	compound	B-Amino_acid
acid	NN	compound	I-Amino_acid
uptake	NN	nmod	O
in	IN	case	O
terms	NNS	nmod	O
of	IN	case	O
their	PRP$	poss	O
accuracy	NN	nmod	O
in	IN	mark	O
evaluating	VBG	acl	O
the	DT	det	O
malignancy	NN	compound	O
grade	NN	dobj	O
of	IN	prep	O
primary	JJ	amod	O
brain	NN	compound	B-Cancer
tumours	NNS	pobj	I-Cancer
.	.	punct	O

PTHrP	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
also	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
skeletal	JJ	amod	B-Organ
metastases	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
dysregulated	VBN	amod	O
expression	NN	nsubj	O
in	IN	case	O
advanced	JJ	amod	O
cancers	NNS	nmod	B-Cancer
causes	VBZ	conj	O
malignancy	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
hypercalcemia	NN	dobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
development	NN	nsubjpass	O
of	IN	case	O
consumption	NN	compound	O
coagulopathy	NN	nmod	O
characterized	VBN	acl	O
by	IN	case	O
progression	NN	nmod	O
from	IN	case	O
hypercoagulable	JJ	amod	O
state	NN	nmod	O
to	TO	mark	O
disseminated	VBN	acl	O
intravascular	JJ	amod	B-Immaterial_anatomical_entity
coagulation	NN	dobj	O
has	VBZ	aux	O
also	RB	advmod	O
been	VBN	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
several	JJ	amod	O
cases	NNS	nmod	O
.	.	punct	O

Lactate	NN	nsubjpass	B-Simple_chemical
and	CC	cc	O
pyruvate	NN	conj	B-Simple_chemical
,	,	punct	O
the	DT	det	O
end	NN	compound	O
products	NNS	appos	O
of	IN	case	O
glycolysis	NN	nmod	O
,	,	punct	O
are	VBP	auxpass	O
highly	RB	advmod	O
produced	VBN	ROOT	O
by	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
even	RB	advmod	O
in	IN	case	O
the	DT	det	O
presence	NN	dep	O
of	IN	case	O
oxygen	NN	nmod	B-Simple_chemical
.	.	punct	O

An	DT	det	O
unusual	JJ	amod	O
primary	JJ	amod	O
adenomatoid	JJ	compound	B-Cancer
tumour	NN	nsubjpass	I-Cancer
arising	VBG	acl	O
in	IN	case	O
the	DT	det	O
normal	JJ	amod	O
liver	NN	nmod	B-Organ
is	VBZ	auxpass	O
described	VBN	ROOT	O
.	.	punct	O

Urokinase	NN	compound	B-Gene_or_gene_product
receptor	NN	ROOT	I-Gene_or_gene_product
:	:	punct	O
a	DT	det	O
molecular	JJ	amod	O
organizer	NN	dep	O
in	IN	case	O
cellular	JJ	amod	B-Cell
communication	NN	nmod	O
.	.	punct	O

[	-LRB-	punct	O
Effects	NNS	ROOT	O
of	IN	case	O
Epstein	NNP	compound	B-Organism
-	HYPH	punct	I-Organism
Barr	NN	compound	I-Organism
virus	NN	compound	I-Organism
latent	JJ	amod	B-Gene_or_gene_product
membrane	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
EBV	NN	compound	B-Organism
-	:	punct	O
LMP1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
on	IN	case	O
related	JJ	amod	O
factors	NNS	nmod	O
of	IN	case	O
metastasis	NN	nmod	O
of	IN	case	O
nasopharyngeal	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	compound	I-Cell
CNE1	NN	nmod	I-Cell
]	-RRB-	punct	O
.	.	punct	O

Enhanced	VBN	amod	O
IGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
expression	NN	nsubj	O
improves	VBZ	ROOT	O
smooth	JJ	amod	B-Cell
muscle	NN	compound	I-Cell
cell	NN	dobj	I-Cell
engraftment	NN	amod	O
after	IN	case	O
cell	NN	compound	B-Cell
transplantation	NN	nmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
screened	VBD	dep	O
the	DT	det	O
expression	NN	compound	O
profile	NN	dobj	O
of	IN	case	O
AQP0	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
12	CD	dep	I-Gene_or_gene_product
in	IN	case	O
breast	NN	compound	B-Tissue
cancer	NN	compound	I-Tissue
tissues	NNS	nmod	I-Tissue
and	CC	cc	O
corresponding	VBG	conj	O
normal	JJ	amod	B-Tissue
tissues	NNS	dobj	I-Tissue
by	IN	case	O
RT	NN	compound	O
-	HYPH	punct	O
PCR	NN	nmod	O
,	,	punct	O
Western	NN	compound	O
blotting	NN	conj	O
and	CC	cc	O
immunohistochemistry	NN	conj	O
.	.	punct	O

Significantly	RB	advmod	O
,	,	punct	O
phenotypic	JJ	amod	O
reversion	NN	nsubj	O
of	IN	case	O
malignant	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
via	IN	case	O
reexpression	NN	nmod	O
of	IN	case	O
HoxD10	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
lost	VBN	acl:relcl	O
in	IN	case	O
malignant	JJ	amod	O
progression	NN	nmod	O
,	,	punct	O
significantly	RB	advmod	O
attenuated	VBD	ROOT	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
in	IN	case	O
a	DT	det	O
hypoxia	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
1alpha	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	O
independent	JJ	amod	O
fashion	NN	nmod	O
and	CC	cc	O
reduced	VBD	amod	O
EC	NN	compound	B-Cell
migration	NN	conj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
a	DT	det	O
selective	JJ	amod	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
inhibitor	NN	nmod	O
,	,	punct	O
NEMO	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
binding	NN	compound	I-Simple_chemical
domain	NN	compound	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
NBD	NN	compound	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
peptide	NN	appos	I-Simple_chemical
,	,	punct	O
on	IN	case	O
metastasis	NN	nmod	O
in	IN	case	O
GSAS	NN	nmod:npmod	B-Cell
/	:	punct	I-Cell
N5	NN	nmod:npmod	I-Cell
-	HYPH	punct	O
engrafted	VBN	amod	O
mice	NNS	nmod	B-Organism
were	VBD	auxpass	O
assessed	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
engrafted	VBN	amod	O
tongue	NN	compound	B-Cancer
tumors	NNS	nsubjpass	I-Cancer
were	VBD	auxpass	O
immunohistochemically	RB	advmod	O
examined	VBN	conj	O
.	.	punct	O

Since	IN	mark	O
AP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappa	NN	compound	I-Gene_or_gene_product
B	NN	nsubj	I-Gene_or_gene_product
are	VBP	cop	O
key	JJ	amod	O
elements	NNS	advcl	O
in	IN	mark	O
controlling	VBG	acl	O
interleukin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
8	CD	intj	I-Gene_or_gene_product
(	-LRB-	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	dobj	I-Gene_or_gene_product
)	-RRB-	punct	O
transcription	NN	dobj	O
,	,	punct	O
human	JJ	amod	B-Organism
fibroblasts	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
treated	VBN	ROOT	O
with	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
MSH	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
beta	NN	conj	I-Gene_or_gene_product
for	IN	case	O
24	CD	nummod	O
hours	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
cytokine	NN	compound	O
levels	NNS	nsubjpass	O
in	IN	case	O
the	DT	det	O
supernatants	NNS	nmod	O
were	VBD	auxpass	O
measured	VBN	conj	O
by	IN	case	O
ELISA	NN	nmod	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
skin	NN	compound	B-Tissue
microvasculature	NN	compound	I-Tissue
angiogenesis	NN	nmod	O
,	,	punct	O
cell	NN	compound	B-Cell
migration	NN	conj	O
,	,	punct	O
and	CC	cc	O
permeability	NN	conj	O
by	IN	case	O
a	DT	det	O
specific	JJ	amod	O
inhibitor	NN	nmod	O
of	IN	case	O
PKCalpha	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Ras	NN	compound	B-Gene_or_gene_product
p21	NN	compound	I-Gene_or_gene_product
onco	JJ	compound	O
-	HYPH	punct	O
protein	NN	ROOT	O
in	IN	case	O
the	DT	det	O
sera	NN	nmod	B-Organism_substance
of	IN	case	O
mice	NNS	nmod	B-Organism
carrying	VBG	acl	O
an	DT	det	O
experimentally	RB	advmod	O
induced	VBN	amod	O
tumor	NN	dobj	B-Cancer
and	CC	cc	O
in	IN	case	O
human	JJ	amod	B-Organism
cancer	NN	compound	B-Cancer
patients	NNS	conj	B-Organism
.	.	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
recently	RB	advmod	O
reported	VBN	ROOT	O
for	IN	case	O
its	PRP$	nmod:poss	O
anticancer	NN	compound	B-Cancer
effect	NN	nmod	O
on	IN	case	O
several	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
in	FW	compound	O
vitro	FW	advmod	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	nsubjpass	O
of	IN	case	O
this	DT	det	O
anticancer	NN	compound	B-Cancer
effect	NN	nmod	O
are	VBP	auxpass	O
not	RB	neg	O
fully	RB	advmod	O
understood	VBN	advcl	O
.	.	punct	O

Similarly	RB	advmod	O
to	TO	case	O
other	JJ	amod	O
members	NNS	advcl	O
of	IN	case	O
this	DT	det	O
family	NN	nmod	O
,	,	punct	O
Id	NN	compound	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
1	CD	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
repression	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
differentiation	NN	nmod	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
cell	NN	compound	B-Cell
growth	NN	nmod	O
.	.	punct	O

This	DT	det	O
growth	NN	compound	O
factor	NN	compound	O
system	NN	nsubj	O
exerts	VBZ	ROOT	O
multiple	JJ	amod	O
physiologic	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
the	DT	det	O
vasculature	NN	nmod	B-Anatomical_system
through	IN	case	O
both	CC	cc:preconj	O
endocrine	JJ	amod	O
and	CC	cc	O
autocrine	JJ	conj	O
/	:	punct	O
paracrine	JJ	dep	O
mechanisms	NNS	nmod	O
.	.	punct	O

Therefore	RB	advmod	O
we	PRP	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
HKa	NN	nsubj	B-Gene_or_gene_product
through	IN	case	O
its	PRP$	nmod:poss	O
D5	NN	compound	O
domain	NN	nmod	O
alters	VBZ	ccomp	O
P13	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	O
Akt	NN	compound	B-Gene_or_gene_product
signaling	NN	dobj	O
to	TO	mark	O
inhibit	VB	xcomp	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	dobj	O
through	IN	case	O
alterations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
focal	JJ	amod	B-Cellular_component
adhesions	NNS	nmod	I-Cellular_component
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
In	IN	case	O
this	DT	det	O
article	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
report	VBP	dep	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	mark	O
altering	VBG	acl	O
RASSF1C	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Glucose	NN	compound	B-Simple_chemical
deprivation	NN	nsubj	O
enhanced	VBD	ROOT	O
death	NN	compound	O
receptor	NN	npadvmod	O
-	HYPH	punct	O
triggered	VBN	amod	O
formation	NN	dobj	O
of	IN	case	O
death	NN	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducing	VBG	amod	I-Gene_or_gene_product
signaling	NN	compound	I-Gene_or_gene_product
complex	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
early	JJ	amod	O
processing	NN	conj	O
of	IN	case	O
procaspase	NN	nmod	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

IGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
transfected	VBN	amod	O
cells	NNS	nsubj	B-Cell
demonstrated	VBD	ROOT	O
greater	JJR	amod	O
cell	NN	compound	B-Cell
proliferation	NN	dobj	O
,	,	punct	O
stimulated	VBN	amod	O
angiogenesis	NN	conj	O
,	,	punct	O
and	CC	cc	O
decreased	VBN	amod	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
activity	NN	conj	O
after	IN	case	O
simulated	JJ	amod	O
ischemia	NN	nmod	O
and	CC	cc	O
reperfusion	NN	conj	O
(	-LRB-	punct	O
P	NN	appos	O
less	JJR	advmod	O
than	IN	mwe	O
0	CD	dep	O
.	.	punct	O
05	CD	dep	O
for	IN	case	O
all	DT	det	O
groups	NNS	nmod	O
compared	VBN	case	O
with	IN	case	O
vector	NN	nmod	O
or	CC	cc	O
cell	NN	compound	B-Cell
controls	NNS	conj	O
)	-RRB-	punct	O
.	.	punct	O

Angiogenesis	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
fundamental	JJ	amod	O
process	NN	ROOT	O
to	TO	case	O
normal	JJ	nmod	O
and	CC	cc	O
abnormal	JJ	conj	O
tissue	NN	compound	B-Tissue
growth	NN	dep	O
and	CC	cc	O
repair	NN	conj	O
,	,	punct	O
which	WDT	nsubj	O
consists	VBZ	acl:relcl	O
of	IN	mark	O
recruiting	VBG	advcl	O
endothelial	JJ	amod	B-Cell
cells	NNS	dobj	I-Cell
toward	IN	case	O
an	DT	det	O
angiogenic	JJ	amod	O
stimulus	NN	nmod	O
.	.	punct	O

More	JJR	amod	O
than	IN	quantmod	O
50	CD	nummod	O
%	NN	nsubj	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
coexpressed	VBD	ROOT	O
vimentin	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
keratin	NN	conj	B-Gene_or_gene_product
.	.	punct	O

No	DT	neg	O
other	JJ	amod	O
structural	JJ	amod	O
changes	NNS	nsubjpass	O
in	IN	case	O
serum	NN	nmod	B-Organism_substance
were	VBD	auxpass	O
observed	VBN	ROOT	O
for	IN	case	O
cholesterol	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
based	VBN	amod	I-Simple_chemical
lipoplexes	NNS	nmod	I-Simple_chemical
.	.	punct	O

This	DT	det	O
altered	JJ	amod	O
energy	NN	compound	O
dependency	NN	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
as	IN	prep	O
the	DT	det	O
"	``	punct	O
Warburg	NNP	compound	O
effect	NN	pobj	O
"	''	punct	O
and	CC	cc	O
is	VBZ	cop	O
a	DT	det	O
hallmark	NN	conj	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Acute	JJ	amod	O
ethanol	NN	compound	B-Simple_chemical
exposure	NN	nsubj	O
disrupts	VBZ	ROOT	O
VEGF	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
cell	NN	compound	B-Cell
signaling	NN	dobj	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Opinions	NNS	nsubjpass	O
on	IN	case	O
3	CD	nummod	O
areas	NNS	nmod	O
were	VBD	auxpass	O
sought	VBN	ROOT	O
:	:	punct	O
pulp	JJ	amod	B-Tissue
therapy	NN	dobj	O
for	IN	case	O
cariously	RB	advmod	O
involved	VBN	amod	O
primary	JJ	amod	O
teeth	NNS	nmod	B-Organ
;	:	punct	O
indirect	JJ	amod	O
pulp	JJ	amod	B-Tissue
treatment	NN	parataxis	O
(	-LRB-	punct	O
IPT	NN	appos	O
)	-RRB-	punct	O
for	IN	case	O
cariously	RB	advmod	O
involved	VBN	amod	O
immature	JJ	amod	O
permanent	JJ	amod	O
teeth	NNS	nmod	B-Organ
;	:	punct	O
and	CC	cc	O
innovative	JJ	amod	O
treatment	NN	compound	O
options	NNS	conj	O
including	VBG	case	O
pulpal	JJ	amod	B-Tissue
revascularization	NN	nmod	O
and	CC	cc	O
regeneration	NN	conj	O
.	.	punct	O

The	DT	det	O
region	NN	nsubj	O
contains	VBZ	ROOT	O
a	DT	det	O
number	NN	dobj	O
of	IN	prep	O
small	JJ	amod	O
open	JJ	amod	O
reading	NN	compound	O
frames	NNS	pobj	O
on	IN	case	O
each	DT	det	O
side	NN	nmod	O
and	CC	cc	O
within	IN	case	O
the	DT	det	O
MSRs	NNP	conj	B-Gene_or_gene_product
.	.	punct	O

Numerous	JJ	amod	O
products	NNS	nsubjpass	O
from	IN	prep	O
fruits	NNS	pobj	B-Organism_subdivision
,	,	punct	O
vegetable	JJ	amod	B-Organism_subdivision
and	CC	cc	O
traditional	JJ	amod	O
medicinal	JJ	amod	O
plants	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
described	VBN	ROOT	O
which	WDT	nsubj	O
can	MD	aux	O
suppress	VB	ccomp	O
TNF	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
and	CC	cc	O
TNF	NN	compound	B-Gene_or_gene_product
signaling	NN	conj	O
but	CC	cc	O
their	PRP$	nmod:poss	O
clinical	JJ	amod	O
potential	NN	nsubj	O
is	VBZ	cop	O
yet	RB	advmod	O
uncertain	JJ	conj	O
.	.	punct	O

This	DT	det	O
result	NN	nsubj	O
suggested	VBD	ROOT	O
that	IN	mark	O
either	CC	cc:preconj	O
the	DT	det	O
structural	JJ	nsubjpass	O
or	CC	cc	O
the	DT	det	O
functional	JJ	amod	O
integrity	NN	conj	O
of	IN	case	O
the	DT	det	O
J	NN	compound	O
domain	NN	nmod	O
is	VBZ	auxpass	O
required	VBN	ccomp	O
to	TO	mark	O
sensitize	VB	xcomp	O
cells	NNS	dobj	B-Cell
to	TO	case	O
apoptosis	NN	nmod	O
.	.	punct	O

Also	RB	advmod	O
,	,	punct	O
rk	RB	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nsubj	I-Gene_or_gene_product
diminished	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
-	SYM	punct	B-Gene_or_gene_product
9	CD	nmod	I-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
mouse	NN	compound	B-Organism
lung	NN	nmod	B-Organ
which	WDT	nsubj	O
induces	VBZ	acl:relcl	O
tumor	NN	compound	B-Cancer
metastasis	NN	dobj	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

TEL	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
member	NN	ROOT	O
of	IN	case	O
the	DT	det	O
ETS	NN	compound	B-Gene_or_gene_product
family	NN	nmod	O
of	IN	case	O
transcription	NN	compound	O
factors	NNS	nmod	O
that	WDT	nsubj	O
interacts	VBZ	acl:relcl	O
with	IN	case	O
the	DT	dep	O
mSin3	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
SMRT	NN	conj	B-Gene_or_gene_product
corepressors	NNS	dep	O
to	TO	mark	O
regulate	VB	xcomp	O
transcription	NN	dobj	O
.	.	punct	O

In	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
elucidate	VB	advcl	O
a	DT	det	O
mechanism	NN	dobj	O
for	IN	case	O
cancer	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
induced	VBN	amod	O
osteoclastogenesis	NN	nmod	O
,	,	punct	O
cells	NNS	conj	B-Cell
from	IN	case	O
a	DT	det	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
line	NN	nmod	O
,	,	punct	O
MDA	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MB	NNP	appos	I-Cell
-	:	punct	I-Cell
231	CD	nummod	I-Cell
,	,	punct	O
were	VBD	auxpass	O
directly	RB	advmod	O
co	NN	advmod	O
-	HYPH	punct	O
cultured	VBN	ROOT	O
with	IN	case	O
ST2	NN	nmod	B-Cell
,	,	punct	O
MC3T3	NN	compound	B-Cell
-	HYPH	punct	I-Cell
E1	NN	conj	I-Cell
,	,	punct	O
or	CC	cc	O
with	IN	case	O
primary	JJ	amod	O
mouse	NN	compound	B-Organism
calvarial	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

rho	NN	ROOT	B-Gene_or_gene_product
genes	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
found	VBN	ccomp	O
in	IN	case	O
both	CC	cc:preconj	O
lower	JJR	nmod	O
and	CC	cc	O
higher	JJR	conj	O
eucaryotes	NNS	dep	O
.	.	punct	O

TGFbeta1	NNP	ROOT	B-Gene_or_gene_product
,	,	punct	O
back	RB	advmod	O
to	IN	prep	O
the	DT	det	O
future	NN	pobj	O
:	:	punct	O
revisiting	VBG	dep	O
its	PRP$	nmod:poss	O
role	NN	dobj	O
as	IN	case	O
a	DT	det	O
transforming	VBG	amod	O
growth	NN	compound	O
factor	NN	nmod	O
.	.	punct	O

This	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
Ets	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
may	MD	aux	O
be	VB	cop	O
relevant	JJ	ROOT	O
for	IN	case	O
reendothelialization	NN	nmod	O
by	IN	mark	O
regulating	VBG	advcl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
certain	JJ	amod	O
genes	NNS	nmod	O
.	.	punct	O

Wnt	NN	compound	B-Gene_or_gene_product
signaling	NN	ROOT	O
,	,	punct	O
stem	NN	compound	B-Cell
cells	NNS	conj	I-Cell
,	,	punct	O
and	CC	cc	O
the	DT	det	O
cellular	JJ	amod	B-Cell
origin	NN	conj	O
of	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Pak1	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
DLC1	NN	compound	B-Gene_or_gene_product
interaction	NN	nsubj	O
plays	VBZ	ROOT	O
an	DT	det	O
essential	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
cell	NN	compound	B-Cell
survival	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
depends	VBZ	acl:relcl	O
on	IN	case	O
Pak1	NN	nmod:poss	B-Gene_or_gene_product
'	POS	case	O
s	VBZ	compound	O
phosphorylation	NN	nmod	O
of	IN	case	O
DLC1	NN	nmod	B-Gene_or_gene_product
on	IN	case	O
Ser88	NN	nmod	B-Amino_acid
.	.	punct	O

In	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
there	EX	expl	O
are	VBP	ROOT	O
conflicting	VBG	amod	O
studies	NNS	nsubj	O
questioning	VBG	acl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
angiogenin	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Insulin	NN	compound	B-Gene_or_gene_product
treatment	NN	nsubj	O
also	RB	advmod	O
increased	VBD	ROOT	O
VEGF	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
levels	NNS	dobj	O
in	IN	case	O
conditioned	JJ	amod	O
RPE	NN	compound	B-Cell
cell	NN	compound	I-Cell
media	NNS	nmod	O
in	IN	case	O
a	DT	det	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
with	IN	case	O
a	DT	det	O
median	JJ	amod	O
effective	JJ	amod	O
concentration	NN	nmod	O
of	IN	case	O
5	CD	nummod	O
nM	NN	nmod	O
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
Merlin	NN	compound	B-Gene_or_gene_product
protein	NN	nsubj	O
might	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
the	DT	det	O
initiation	NN	nmod	O
of	IN	case	O
metastasis	NN	nmod	O
of	IN	case	O
NSCLC	NN	nmod	B-Cancer
.	.	punct	O

All	DT	nsubj	O
of	IN	case	O
the	DT	det	O
clones	NNS	nmod	B-Cell
in	IN	case	O
culture	NN	nmod	O
showed	VBD	ROOT	O
almost	RB	advmod	O
the	DT	det	O
same	JJ	amod	O
low	JJ	amod	O
level	NN	dobj	O
of	IN	case	O
metastatic	JJ	amod	O
ability	NN	nmod	O
and	CC	cc	O
exhibited	VBD	conj	O
little	JJ	amod	O
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
oncogene	NN	compound	O
amplification	NN	dobj	O
with	IN	case	O
correspondingly	RB	advmod	O
low	JJ	amod	O
mRNA	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

Lewis	JJ	compound	B-Cancer
lung	NN	compound	I-Cancer
carcinoma	NN	ROOT	I-Cancer
.	.	punct	O

Surprisingly	RB	advmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
further	JJ	amod	O
phosphorylation	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
protein	NN	nmod	O
on	IN	case	O
addition	NN	nmod	O
of	IN	case	O
phorbol	NN	compound	B-Simple_chemical
ester	NN	nmod	I-Simple_chemical
was	VBD	auxpass	O
greatly	RB	advmod	O
reduced	VBN	ROOT	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
reduced	VBN	amod	O
APC	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
level	NN	nsubj	O
increases	VBZ	ccomp	O
intestinal	JJ	amod	B-Pathological_formation
polyp	NN	compound	I-Pathological_formation
multiplicity	NN	dobj	O
through	IN	case	O
quantitative	JJ	amod	O
stimulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
beta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
/	:	punct	O
T	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cell	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
transcription	NN	nmod	O
.	.	punct	O

